<!DOCTYPE html>
<html lang='en'>

<head>
<meta charset="utf-8">
<title>Jencycla - FDA prescribing information, side effects and uses</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="description" content="Jencycla official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.">
<meta name="referrer" content="origin-when-cross-origin">
<link rel='canonical' href='https://www.drugs.com/pro/jencycla.html'>
<link rel='search' type='application/opensearchdescription+xml' href='/opensearch.xml' title='Drugs.com'>
<!-- Facebook Open Graph Summary -->
<meta property="fb:app_id" content="1470988726468809">
<meta property="article:author" content="https://www.facebook.com/Drugscom">
<meta property="article:publisher" content="https://www.facebook.com/Drugscom">
<meta property="og:title" content="Jencycla - FDA prescribing information, side effects and uses">
<meta property="og:image" content="https://www.drugs.com/img/social/ddc-opengraph-logomark.png">
<meta property="og:site_name" content="Drugs.com">
<meta property="og:locale" content="en_US">
<meta property="og:type" content="article">
<meta property='og:description' content="Jencycla official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.">
<meta property='og:url' content="https://www.drugs.com/pro/jencycla.html">
<!-- Twitter Summary Card -->
<meta name="twitter:card" content="summary">
<meta name="twitter:site" content="@drugscom">
<meta name="twitter:title" content="Jencycla - FDA prescribing information, side effects and uses">
<meta name="twitter:image" content="https://www.drugs.com/img/social/ddc-opengraph-logomark.png">
<meta name='twitter:description' content="Jencycla official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.">
<!-- Favicons -->
<link rel='manifest' href='/manifest.json'>
<link rel='icon' type='image/png' sizes='32x32' href='/img/logo/favicon/ddc-icon-32x32.png'>
<link rel='icon' type='image/png' sizes='16x16' href='/img/logo/favicon/ddc-icon-16x16.png'>
<link rel='apple-touch-icon' sizes='180x180' href='/img/logo/favicon/apple-touch-icon-180x180.png'>
<meta name='theme-color' content='#259cd8'>
<!-- CSS -->
<style>body{margin:0;padding:0;}img{max-width:100%;height:auto;}.contentBox{overflow-wrap:break-word;word-wrap:break-word;}</style>
<link rel='stylesheet' href='/bundle/css/ddc-pack-site.min.fde32fb9.css'>
<link rel='stylesheet' href='/bundle/css/component/component.nav-toc.min.e724a1c8.css'>
<link rel='stylesheet' href='/bundle/css/section/ddc-section-pro.min.5fb861d5.css'>
<link rel='stylesheet' href='/bundle/css/ddc-print.min.e6665d40.css' media='print'>
<!-- Schema -->
<script type='application/ld+json'>[{"@context":"http://schema.org/","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Professionals","item":{"@type":"MedicalWebPage","@id":"https://www.drugs.com/professionals.html"}},{"@type":"ListItem","position":2,"name":"FDA PI","item":{"@type":"MedicalWebPage","@id":"https://www.drugs.com/pro/"}},{"@type":"ListItem","position":3,"name":"Jencycla","item":{"@type":"MedicalWebPage","@id":"https://www.drugs.com/pro/jencycla.html#"}}]},{"@context":"http://schema.org/","@type":"MedicalWebPage","@id":"https://www.drugs.com/pro/jencycla.html","url":"https://www.drugs.com/pro/jencycla.html","audience":{"@context":"https://schema.org","@type":"medicalAudience","audienceType":["Patient","Clinician","MedicalResearcher"]},"publisher":{"@context":"http://schema.org/","@type":"Organization","@id":"https://www.drugs.com/#organization","name":"Drugs.com","url":"https://www.drugs.com","logo":{"@context":"http://schema.org","@type":"ImageObject","url":"https://www.drugs.com/img/logo/schema/drugscom-logo-600x60.png","width":600,"height":60}},"image":{"@type":"ImageObject","contentUrl":"https://www.drugs.com/images/pills/custom/pill20867-1/jencycla.jpg","url":"https://www.drugs.com/images/pills/custom/pill20867-1/jencycla.jpg","caption":"Jencycla (norethindrone) 0.35 mg"},"about":{"@type":"Drug","@id":"https://www.drugs.com/pro/jencycla.html#Jencycla","name":"Jencycla","nonProprietaryName":"norethindrone","pregnancyCategory":"http://schema.org/FDAcategoryX","pregnancyWarning":"Not for use in pregnancy","prescriptionStatus":"http://schema.org/PrescriptionOnly","image":{"@type":"ImageObject","contentUrl":"https://www.drugs.com/images/pills/custom/pill20867-1/jencycla.jpg","url":"https://www.drugs.com/images/pills/custom/pill20867-1/jencycla.jpg","caption":"Jencycla (norethindrone) 0.35 mg"}},"reviewedBy":{"@context":"http://schema.org/","@type":"Organization","@id":"https://www.drugs.com/#organization","name":"Drugs.com","url":"https://www.drugs.com","logo":{"@context":"http://schema.org","@type":"ImageObject","url":"https://www.drugs.com/img/logo/schema/drugscom-logo-600x60.png","width":600,"height":60}},"lastReviewed":"2020-07-01 00:00:00","name":"Jencycla","description":"Jencycla official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology."},{"@context":"https://schema.org","@graph":[{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Overview","url":"https://www.drugs.com/cdi/jencycla.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Side Effects","url":"https://www.drugs.com/sfx/jencycla-side-effects.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Dosage","url":"https://www.drugs.com/dosage/jencycla.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Professional","url":"https://www.drugs.com/pro/jencycla.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Interactions","url":"https://www.drugs.com/drug-interactions/norethindrone,jencycla.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Pregnancy Warnings","url":"https://www.drugs.com/pregnancy/norethindrone.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Breastfeeding Warnings","url":"https://www.drugs.com/breastfeeding/norethindrone.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"User Reviews","url":"https://www.drugs.com/comments/norethindrone/jencycla.html"},{"@context":"http://schema.org/","@type":"SiteNavigationElement","name":"Drug Images","url":"https://www.drugs.com/jencycla-images.html"}]}]</script>
</head>

<body class='page-section-pro page-doctype-content page-pro-jencycla-html'>


<a class='ddc-skiplink-content' href='#content'>Skip to Content</a>


<header id="header">
	<div class="top-container">

		<div class="header-wrap container">
			<div class="header">

				<div class="brand">
					<a href="//www.drugs.com/">
						<img class='logo' src='/img/logo/drugscom-logo.svg' alt="Drugs.com" width='280' height='58' data-ga-category="Top Nav" data-ga-action="Logo">
					</a>
				</div>
				<form method='get' action='/search.php' class='search-main'>
					<div class="input-group-attached">
						<label class="ddc-form-label-placeholder" for="livesearch-main">Search Drugs.com</label>
						<input type="text" id="livesearch-main" name="searchterm" data-required="1" data-value="Jencycla" class="livesearch webkit-speech" placeholder="Search" value="" maxlength="70" />

						<div class="search-filter">
							<div class="nav-facade-active header-select-wrapper">
								<span class="search-filter__label" data-value="search-alias=aps">
									<span data-search-select-value>All</span>
									<svg class='ddc-icon ddc-icon-down' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z' /></svg>								</span>
								<label>
									<span class="ddc-sr-only">Select the section you want to search in</span>
									<select name="sources[]" class="search-filter__select" data-search-select>
<option value=''>All</option>
<option value='consumer'>Consumer</option>
<option value='professional'>Professional</option>
<option value='drugimages'>Pill ID</option>
<option value='interactions'>Interactions</option>
<option value='news'>News</option>
<option value='fdaalerts'>FDA Alerts</option>
<option value='newdrugapprovals'>Approvals</option>
<option value='newdrugapplications'>Pipeline</option>
<option value='clinicaltrials'>Clinical Trials</option>
<option value='cg'>Care Notes</option>
<option value='natural'>Natural Products</option>
									</select>
								</label>
							</div>

						</div>

						<a href="#" class='search-close' role='button'>
							<span class="ddc-sr-only">Close</span>
							<span class='search-close-icon'>
								<svg class='ddc-icon ddc-icon-close' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M17 5.94L18.06 7l-5 5 5 5L17 18.06l-5-5-5 5L5.94 17l5-5-5-5L7 5.94l5 5 5-5z' /></svg>							</span>
						</a>

						<button class='ddc-btn'>
							<span class='ddc-sr-only'>Search</span>
							<svg class='ddc-icon ddc-icon-search' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M10 2a8 8 0 016.32 12.9l5.6 5.6-1.42 1.41-5.6-5.59A8 8 0 1110 2zm0 2a6 6 0 100 12 6 6 0 000-12z' /></svg>						</button>
					</div>

					<div class="ddc-link-no-visited search-browse">
						Browse all medications:
						<span class="alpha-list">
<a href='/alpha/a.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='a'>a</a>
<a href='/alpha/b.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='b'>b</a>
<a href='/alpha/c.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='c'>c</a>
<a href='/alpha/d.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='d'>d</a>
<a href='/alpha/e.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='e'>e</a>
<a href='/alpha/f.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='f'>f</a>
<a href='/alpha/g.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='g'>g</a>
<a href='/alpha/h.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='h'>h</a>
<a href='/alpha/i.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='i'>i</a>
<a href='/alpha/j.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='j'>j</a>
<a href='/alpha/k.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='k'>k</a>
<a href='/alpha/l.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='l'>l</a>
<a href='/alpha/m.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='m'>m</a>
<a href='/alpha/n.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='n'>n</a>
<a href='/alpha/o.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='o'>o</a>
<a href='/alpha/p.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='p'>p</a>
<a href='/alpha/q.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='q'>q</a>
<a href='/alpha/r.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='r'>r</a>
<a href='/alpha/s.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='s'>s</a>
<a href='/alpha/t.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='t'>t</a>
<a href='/alpha/u.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='u'>u</a>
<a href='/alpha/v.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='v'>v</a>
<a href='/alpha/w.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='w'>w</a>
<a href='/alpha/x.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='x'>x</a>
<a href='/alpha/y.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='y'>y</a>
<a href='/alpha/z.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='z'>z</a>
<a href='/alpha/0-9.html' data-ga-category='Top Nav' data-ga-action='Alpha' data-ga-label='0-9'>0-9</a>
						</span>
						<div class="search-browse-options">
							<a href="/search_advanced.html" data-ga-category="Top Nav" data-ga-action="Advanced Search">Advanced Search</a>
						</div>
					</div>
				</form>
				<nav class='ddc-nav-account'>
					<a class='ddc-btn ddc-btn-empty ddc-btn-sm ddc-btn-register' rel='nofollow' href='/account/register/'>Register</a>
					<a class='ddc-btn ddc-btn-secondary ddc-btn-sm' rel='nofollow' href='/account/login/'>Sign In</a>
				</nav>
				<div class='nav-block'>
					<a href='#' data-nav-toggle data-ga-category="Top Nav" data-ga-action="Hamburger" role='button'>
						<span class='ddc-sr-only'>Main navigation</span>
						<svg class='ddc-icon ddc-icon-menu' width='28' height='28' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M21 17v2H3v-2h18zm0-6v2H3v-2h18zm0-6v2H3V5h18z' /></svg>						<svg class='ddc-icon ddc-icon-close' width='32' height='32' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M17 5.94L18.06 7l-5 5 5 5L17 18.06l-5-5-5 5L5.94 17l5-5-5-5L7 5.94l5 5 5-5z' /></svg>					</a>
				</div>

			</div>
		</div>
	</div>


<nav class='ddc-nav'>
		<ul>
					<li class='ddc-nav-item'>
				<a href='/account/' rel='nofollow'>Account</a>
				<ul>
					<li><a href='/account/login/' rel='nofollow'>Sign In</a></li>
					<li><a href='/account/register/' rel='nofollow'>Register</a></li>
				</ul>
			</li>
					<li class='ddc-nav-item'><a href='/drug_information.html'>Drugs A-Z</a></li>
		<li class='ddc-nav-item'><a href='/pill_identification.html'>Pill Identifier</a></li>
		<li class='ddc-nav-item'><a href='/drug_interactions.html'>Interactions Checker</a></li>
		<li class='ddc-nav-item'><a href='/news.html'>News &amp; Alerts</a></li>
		<li class='ddc-nav-item'><a href='/professionals.html'>Pro Edition</a></li>
		<li class='ddc-nav-item'><a href='/sitemap.html'>More<span class='ddc-sr-only'> Resources</span></a></li>
	</ul>
</nav>

</header>


<div class='topbanner-wrap'>
<div id='drugs-drugs-1' class='display-ad display-ad-728x90'>
<script>
var ehs_ad_called = ++ehs_ad_called || 1;
</script>
</div>
<script src='//ads.ehealthcaresolutions.com/a/?adid=drugs-drugs-1&slotid=1&url=www.drugs.com%2Fpro%2Fjencycla.html&size=728x90&vpos=t&hpos=l&site=ehs.pro.drugs.drugs&drg=norethindrone&drg=Jencycla&drc=contraceptives&drc=progestins&dra=1' defer></script>
	<button class='ddc-topbanner-close' data-toggle-class='.topbanner-wrap'>
		<span class='ddc-sr-only'>Close</span>
		<svg class='ddc-icon ddc-icon-close' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M17 5.94L18.06 7l-5 5 5 5L17 18.06l-5-5-5 5L5.94 17l5-5-5-5L7 5.94l5 5 5-5z' /></svg>	</button>
</div>

<main id='container' class='container'>

<div id='contentWrap' class='ddc-clear-both'>

<div id='content' class='content'>
<div class='contentHead'>
<nav class='ddc-breadcrumb' aria-label='breadcrumb'>
<ol class='ddc-breadcrumb-3'>
<li class='ddc-breadcrumb-item'><a href='/professionals.html'>Professionals</a></li>
<li class='ddc-breadcrumb-item'><a href='/pro/'>FDA PI</a></li>
<li class='ddc-breadcrumb-item active' aria-current='page'><span>Jencycla</span></li>
</ol>
</nav>
<div class='page-icons page-icons-header'>
<a href='#print' role='button' data-action='print' data-ga-category='social' data-ga-action='DDC' data-ga-label='Print Top'>
<svg class='ddc-icon ddc-icon-print' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M17.75 3.25v4h4v10.5h-4v3H6.25v-3h-4V7.25h4v-4h11.5zm-1.5 9.5h-8.5v6.5h8.5v-6.5zm4-4H3.75v7.5h2.5v-5h11.5v5h2.5v-7.5zm-4-4h-8.5v2.5h8.5v-2.5z' /></svg> Print
</a>
<a href='#save' role='button' data-action='share-mednotes' data-ga-category='social' data-ga-action='DDC' data-ga-label='Save Drug Top'>
<svg class='ddc-icon ddc-icon-save' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M19 15v2.75h2.75v1.5H19V22h-1.5v-2.75h-2.75v-1.5h2.75V15H19zM18 2.25c.9182 0 1.6712.7071 1.7442 1.6065L19.75 4v9h-1.5V4a.2501.2501 0 00-.1927-.2434L18 3.75H6a.2501.2501 0 00-.2434.1927L5.75 4v15.25h7v1.5H5a.7502.7502 0 01-.7432-.6482L4.25 20V4c0-.9182.7071-1.6712 1.6065-1.7442L6 2.25h12zM12.75 13.5V15H8v-1.5h4.75zm3.25-3V12H8v-1.5h8zm0-3V9H8V7.5h8z' /></svg> Save
</a>
</div>
</div>
<!-- google_ad_section_start -->

<div class="contentBox">
<h1>Jencycla</h1>
<p class='drug-subtitle'><b>Generic name:</b> <a href='/mtm/norethindrone.html'>norethindrone</a><br />
<b>Dosage form:</b> tablet<br><b>Drug class:</b> <a href='/drug-class/contraceptives.html'>Contraceptives</a>, <a href='/drug-class/progestins.html'>Progestins</a></p>
	<p class='ddc-reviewed-by'><span><a href='/support/editorial_policy.html#editorial-staff'>Medically reviewed</a> by Drugs.com. Last updated on July 1, 2020.</span></p>
<ul class='nav-tabs nav-tabs-collapse nav-tabs-pill'>
<li><a class='nav-item' href='/cdi/jencycla.html' data-ga-category='In Page Nav' data-ga-action='Top Tab' data-ga-label='Overview'>Overview</a></li>
<li><a class='nav-item' href='/sfx/jencycla-side-effects.html' data-ga-category='In Page Nav' data-ga-action='Top Tab' data-ga-label='Side Effects'>Side Effects</a></li>
<li><a class='nav-item' href='/dosage/jencycla.html' data-action='drug-dosage-disambiguation' data-ddc_id='1730' data-brand_id='16155' data-ga-category='In Page Nav' data-ga-action='Top Tab' data-ga-label='Dosage'>Dosage</a></li>
<li><b class='nav-item here'>Professional</b></li>
<li><a class='nav-item' href='/drug-interactions/norethindrone,jencycla.html' data-ga-category='In Page Nav' data-ga-action='Top Tab' data-ga-label='Interactions'>Interactions</a></li>
	<li class='nav-more'>
		<a class='nav-item' href='#moreResources' rel='nofollow'>More<svg class='ddc-icon ddc-icon-down' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z' /></svg></a>
	</li>
	</ul>





<!-- start intra-page-menu -->
<div id='articleTableOfContents' class='ddc-toc'><h5 class='ddc-toc-heading'>On This Page</h5><div class='ddc-toc-content'><ul>
<li><a href="#s-34089-3">Description</a></li>
<li><a href="#s-34090-1">Clinical Pharmacology</a></li>
<li><a href="#s-34067-9">Indications and Usage</a></li>
<li><a href="#s-34070-3">Contraindications</a></li>
<li><a href="#s-34071-1">Warnings</a></li>
<li><a href="#s-42232-9">Precautions</a></li>
<li><a href="#s-34076-0">Patient Counseling Information</a></li>
<li class='ddc-toggle-hidden'><a href="#s-34084-4">Adverse Reactions/Side Effects</a></li>
<li class='ddc-toggle-hidden'><a href="#s-34088-5">Overdosage</a></li>
<li class='ddc-toggle-hidden'><a href="#s-34068-7">Dosage and Administration</a></li>
<li class='ddc-toggle-hidden'><a href="#s-34069-5">How Supplied/Storage and Handling</a></li>
<li class='ddc-toggle-hidden'><a href="#s-34093-5">References</a></li>
</ul></div><div class='ddc-toc-footer toggle-view-all' data-toggle-class='.ddc-toc'><a class='toggle-btn' href='#' role='button'>Expand <span class='icon icon-arrow-down'></span></a></div></div>
<!-- end intra-page-menu -->

<a id="ID1"></a>
<p class="First"><a id="ID3"></a><span class="Bold">Rx Only</span></p>
<p><span class="Bold">Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.</span></p>

<a id="ID4"></a><a id="s-34089-3"></a>
<h2>Jencycla Description</h2>
<p class="First"><a id="ID5"></a><span class="Bold">Jencycla&trade; Tablets</span></p>
<p>Each tablet contains 0.35 mg norethindrone. Inactive ingredients include D&amp;C yellow No. 10, FD&amp;C blue No. 1, lactose anhydrous, magnesium stearate, povidone and sodium starch glycolate.</p>
<p>The chemical name of norethindrone is 17-hydroxy-19-nor-17&alpha;-pregn-4-en-20-yn-3-one. It has a molecular formula of C<span class="Sub">20</span>H<span class="Sub">26</span>O<span class="Sub">2</span> and a molecular weight of 298.4. It has the following structural formula:</p>
<div class="Figure"><img data-lazy-load data-src='https://www.drugs.com/pro/images/e91e7bdd-2984-4332-9b0b-04322792d7f6/c2277aea-d8d0-4c74-8bc5-f3fc386fe8dc-01.jpg' src='/img/pixel.gif' alt="" /></div>
<p><a id="ID80"></a>Jencycla meets USP Dissolution Test 2.</p>

<a id="ID7"></a><a id="s-34090-1"></a>
<h2>Jencycla - Clinical Pharmacology</h2>
<p class="First"><a id="ID8"></a><span class="Bold">1.           Mode of Action</span></p>
<p>Jencycla progestin-only oral contraceptives prevent conception by suppressing ovulation in approximately half of users, thickening the cervical mucus to inhibit sperm penetration, lowering the midcycle LH and FSH peaks, slowing the movement of the ovum through the fallopian tubes, and altering the endometrium.</p>
<p><span class="Bold">2.           Pharmacokinetics</span></p>
<p>Serum progestin levels peak about two hours after oral administration, followed by rapid distribution and elimination. By 24 hours after drug ingestion, serum levels are near baseline, making efficacy dependent upon rigid adherence to the dosing schedule. There are large variations in serum levels among individual users. Progestin-only administration results in lower steady-state serum progestin levels and a shorter elimination half-life than concomitant administration with estrogens.</p>

<a id="ID9"></a><a id="s-34067-9"></a>
<a id='indications'></a><h2>Indications and Usage for Jencycla</h2>
<p class="First"><a id="ID10"></a><span class="Bold">1.           Indications</span></p>
<p>Progestin-only oral contraceptives are indicated for the prevention of pregnancy.</p>
<p><span class="Bold">2.           Efficacy</span></p>
<p>If used perfectly, the first-year failure rate for progestin-only oral contraceptives is 0.5%. However, the typical failure rate is estimated to be closer to 5%, due to late or omitted pills. Table 1 lists the pregnancy rates for users of all major methods of contraception.</p>
<a id="ID11"></a>
<div class='responsive-table-wrap'><table style="width: 100%; ">
<caption>Table 1: Percentage of Women Experiencing an Unintended Pregnancy During the First Year of Typical Use and the First Year of Perfect Use of Contraception and the Percentage Continuing Use at the End of the First Year. United States.</caption>
<col style="width: 31%; " />
<col style="width: 23%; " />
<col style="width: 20%; " />
<col style="width: 26%; " />
<thead>
<tr class="First">
<td class="Toprule" colspan="1" style="text-align: left; vertical-align: top; "><span class="Bold"><br /></span></td>
<td class="Toprule" colspan="2" style="text-align: center; vertical-align: top; "><span class="Bold">% </span><span class="Bold">of </span><span class="Bold">Women </span><span class="Bold">Experiencing </span><span class="Bold">an</span> <span class="Bold"><br /></span> <span class="Bold">Unintended </span><span class="Bold">Pregnancy </span><span class="Bold">within </span><span class="Bold">the</span> <span class="Bold"><br /></span> <span class="Bold">First </span><span class="Bold">Year </span><span class="Bold">of </span><span class="Bold">Use</span> <span class="Bold"><br /></span></td>
<td class="Toprule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">% </span><span class="Bold">of </span><span class="Bold">Women</span> <span class="Bold"><br /></span> <span class="Bold">Continuing </span><span class="Bold">Use </span><span class="Bold">at</span> <span class="Bold"><br /></span> <span class="Bold">One </span><span class="Bold">Year<span class="Sup">3</span></span> <span class="Bold"><br /></span></td>
</tr>
<tr>
<td colspan="1" style="text-align: left; vertical-align: top; "><span class="Bold">Method</span> <span class="Bold"><br /></span></td>
<td colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">Typical </span><span class="Bold">Use </span><span class="Bold"><span class="Sup">1</span></span> <span class="Bold"><br /></span></td>
<td colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">Perfect </span><span class="Bold">Use<span class="Sup">2</span></span> <span class="Bold"><br /></span></td>
<td colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold"><br /></span></td>
</tr>
<tr class="Last">
<td class="Botrule" colspan="1" style="text-align: left; vertical-align: top; "><span class="Bold">Header</span><span class="Bold">$(</span><span class="Bold">1</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
<td class="Botrule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">(</span><span class="Bold">2</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
<td class="Botrule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">(</span><span class="Bold">3</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
<td class="Botrule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">(</span><span class="Bold">4</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
</tr>
</thead>
<tfoot>
<tr class="First">
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Adapted from Hatcher et al, 1998, Ref. # 1.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Emergency Contraceptive Pills: Treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.<span class="Sup">9</span><br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Lactational Amenorrhea Method: LAM is highly effective, temporary method of contraception.<span class="Sup">1</span><span class="Sup">0</span><br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Source: Trussell J, Contraceptive efficacy. In Hatcher RA, Trussell J, Stewart F, Cates W, Stewart GK, Kowal D, Guest F, Contraceptive Technology: Seventeenth Revised Edition. New York NY: Irvington Publishers, 1998.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">1</span>Among <span class="Italics">typical</span> couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">2</span>Among couples who initiate use of a method (not necessarily for the first time) and who use it <span class="Italics">perfectly</span> (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">3</span>Among couples attempting to avoid pregnancy, the percentage who continue to use a method for one year.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">4</span>The percents becoming pregnant in columns (2) and (3) are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant. Among such populations, about 89% become pregnant within one year. This estimate was lowered slightly (to 85%) to represent the percent who would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">5</span>Foams, creams, gels, vaginal suppositories, and vaginal film.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">6</span>Cervical mucus (ovulation) method supplemented by calendar in the pre-ovulatory and basal body temperature in the post-ovulatory phases.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">7</span>With spermicidal cream or jelly.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">8</span>Without spermicides.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">9</span>The treatment schedule is one dose within 72 hours after unprotected intercourse, and a second dose 12 hours after the first dose. The Food and Drug Administration has declared the following brands of oral contraceptives to be safe and effective for emergency contraception: Ovral<span class="Sup">&reg;</span> (1 dose is 2 white pills), Alesse<span class="Sup">&reg;</span> (1 dose is 5 pink pills), Nordette<span class="Sup">&reg;</span> or Levlen<span class="Sup">&reg;</span> (1 dose is 2 light-orange pills), Lo/Ovral<span class="Sup">&reg;</span> (1 dose is 4 white pills), Triphasil<span class="Sup">&reg;</span> or Tri-Levlen<span class="Sup">&reg;</span> (1 dose is 4 yellow pills).<br /></p>
</td>
</tr>
<tr class="Last">
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">1</span><span class="Sup">0</span>However, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency or duration of breastfeeds is reduced, bottle feeds are introduced, or the baby reaches six months of age.<br /></p>
</td>
</tr>
</tfoot>
<tbody>
<tr class="First">
<td class="Toprule" style="text-align: left; vertical-align: top; ">Chance<span class="Sup">4</span><br /></td>
<td class="Toprule" style="text-align: center; vertical-align: top; ">85<br /></td>
<td class="Toprule" style="text-align: center; vertical-align: top; ">85<br /></td>
<td class="Toprule" style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Spermicides<span class="Sup">5</span><br /></td>
<td style="text-align: center; vertical-align: top; ">26<br /></td>
<td style="text-align: center; vertical-align: top; ">6<br /></td>
<td style="text-align: center; vertical-align: top; ">40<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Periodic abstinence<br /></td>
<td style="text-align: center; vertical-align: top; ">25<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">63<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Calendar<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">9<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Ovulation Method<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">3<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Sympto-Thermal<span class="Sup">6</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">2<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Post-Ovulation<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">1<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Cap<span class="Sup">7</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Parous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">40<br /></td>
<td style="text-align: center; vertical-align: top; ">26<br /></td>
<td style="text-align: center; vertical-align: top; ">42<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Nulliparous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">9<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Sponge<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Parous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">40<br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">42<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Nulliparous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">9<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Diaphragm<span class="Sup">7</span><br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">6<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Withdrawal<br /></td>
<td style="text-align: center; vertical-align: top; ">19<br /></td>
<td style="text-align: center; vertical-align: top; ">4<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Condom<span class="Sup">8</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Female (Reality<span class="Sup">&reg;</span>)<br /></td>
<td style="text-align: center; vertical-align: top; ">21<br /></td>
<td style="text-align: center; vertical-align: top; ">5<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Male<br /></td>
<td style="text-align: center; vertical-align: top; ">14<br /></td>
<td style="text-align: center; vertical-align: top; ">3<br /></td>
<td style="text-align: center; vertical-align: top; ">61<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Pill<br /></td>
<td style="text-align: center; vertical-align: top; ">5<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">71<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Progestin Only<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">0.5<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Combined<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">0.1<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">IUD<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Progesterone T<br /></td>
<td style="text-align: center; vertical-align: top; ">2.0<br /></td>
<td style="text-align: center; vertical-align: top; ">1.5<br /></td>
<td style="text-align: center; vertical-align: top; ">81<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Copper T380A<br /></td>
<td style="text-align: center; vertical-align: top; ">0.8<br /></td>
<td style="text-align: center; vertical-align: top; ">0.6<br /></td>
<td style="text-align: center; vertical-align: top; ">78<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     LNg 20<br /></td>
<td style="text-align: center; vertical-align: top; ">0.1<br /></td>
<td style="text-align: center; vertical-align: top; ">0.1<br /></td>
<td style="text-align: center; vertical-align: top; ">81<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Depo-Provera<span class="Sup">&reg;</span><br /></td>
<td style="text-align: center; vertical-align: top; ">0.3<br /></td>
<td style="text-align: center; vertical-align: top; ">0.3<br /></td>
<td style="text-align: center; vertical-align: top; ">70<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Norplant<span class="Sup">&reg;</span> and<br /></td>
<td style="text-align: center; vertical-align: top; ">0.05<br /></td>
<td style="text-align: center; vertical-align: top; ">0.05<br /></td>
<td style="text-align: center; vertical-align: top; ">88<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Norplant-2<span class="Sup">&reg;</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Female Sterilization<br /></td>
<td style="text-align: center; vertical-align: top; ">0.5<br /></td>
<td style="text-align: center; vertical-align: top; ">0.5<br /></td>
<td style="text-align: center; vertical-align: top; ">100<br /></td>
</tr>
<tr class="Last">
<td class="Botrule" style="text-align: left; vertical-align: top; ">Male Sterilization<br /></td>
<td class="Botrule" style="text-align: center; vertical-align: top; ">0.15<br /></td>
<td class="Botrule" style="text-align: center; vertical-align: top; ">0.10<br /></td>
<td class="Botrule" style="text-align: center; vertical-align: top; ">100<br /></td>
</tr>
</tbody>
</table></div>
<p><a id="ID81"></a><span class="Bold Italics">Jencycla Tablets have not been studied for and are not indicated for use in emergency contraception.</span></p>

<a id="ID13"></a><a id="s-34070-3"></a>
<h2>Contraindications</h2>
<p class="First"><a id="ID14"></a>Progestin-only oral contraceptives (POPs) should not be used by women who currently have the following conditions:</p>
<ul>
<li>Known or suspected pregnancy</li>
<li>Known or suspected carcinoma of the breast</li>
<li>Undiagnosed abnormal genital bleeding</li>
<li>Hypersensitivity to any component of this product</li>
<li>Benign or malignant liver tumors</li>
<li>Acute liver disease</li>
</ul>

<a id="ID16"></a><a id="s-34071-1"></a>
<h2>Warnings</h2>
<p class="First"><a id="ID79"></a>Cigarette smoking increases the risk of serious cardiovascular disease. Women who use oral contraceptives should be strongly advised not to smoke.</p>
<p>Jencycla does not contain estrogen and, therefore, this insert does not discuss the serious health risks that have been associated with the estrogen component of combined oral contraceptives (COCs). The healthcare professional is referred to the prescribing information of combined oral contraceptives for a discussion of those risks. The relationship between progestin-only oral contraceptives and these risks is not fully defined. The healthcare professional should remain alert to the earliest manifestation of symptoms of any serious disease and discontinue oral contraceptive therapy when appropriate.</p>
<p><span class="Bold">1.           Ectopic Pregnancy</span></p>
<p>The incidence of ectopic pregnancies for progestin-only oral contraceptive users is 5 per 1000 woman-years. Up to 10% of pregnancies reported in clinical studies of progestin-only oral contraceptive users are extrauterine. Although symptoms of ectopic pregnancy should be watched for, a history of ectopic pregnancy need not be considered a contraindication to use of this contraceptive method. Healthcare professionals should be alert to the possibility of an ectopic pregnancy in women who become pregnant or complain of lower abdominal pain while on progestin-only oral contraceptives.</p>
<p><span class="Bold">2.           Delayed Follicular Atresia/Ovarian Cysts</span></p>
<p>If follicular development occurs, atresia of the follicle is sometimes delayed and the follicle may continue to grow beyond the size it would attain in a normal cycle. Generally these enlarged follicles disappear spontaneously. Often they are asymptomatic; in some cases they are associated with mild abdominal pain. Rarely they may twist or rupture, requiring surgical intervention.</p>
<p><span class="Bold">3.           Irregular Genital Bleeding</span></p>
<p>Irregular menstrual patterns are common among women using progestin-only oral contraceptives. If genital bleeding is suggestive of infection, malignancy or other abnormal conditions, such nonpharmacologic causes should be ruled out. If prolonged amenorrhea occurs, the possibility of pregnancy should be evaluated.</p>
<p><span class="Bold">4.           Carcinoma of the Breast and Reproductive Organs</span></p>
<p>Some epidemiological studies of oral contraceptive users have reported an increased relative risk of developing breast cancer, particularly at a younger age and apparently related to duration of use. These studies have predominantly involved combined oral contraceptives and there is insufficient data to determine whether the use of POPs similarly increases the risk.</p>
<p>A meta-analysis of 54 studies found a small increase in the frequency of having breast cancer diagnosed for women who were currently using combined oral contraceptives or had used them within the past ten years.</p>
<p>This increase in the frequency of breast cancer diagnosis, within ten years of stopping use, was generally accounted for by cancers localized to the breast. There was no increase in the frequency of having breast cancer diagnosed ten or more years after cessation of use.</p>
<p>Women with breast cancer should not use oral contraceptives because the role of female hormones in breast cancer has not been fully determined.</p>
<p>Some studies suggest that oral contraceptive use has been associated with an increase in the risk of cervical intraepithelial neoplasia in some populations of women. However, there continues to be controversy about the extent to which such findings may be due to differences in sexual behavior and other factors. There is insufficient data to determine whether the use of POPs increases the risk of developing cervical intraepithelial neoplasia.</p>
<p><span class="Bold">5.           Hepatic Neoplasia</span></p>
<p>Benign hepatic adenomas are associated with combined oral contraceptive use, although the incidence of benign tumors is rare in the United States. Rupture of benign, hepatic adenomas may cause death through intra-abdominal hemorrhage.</p>
<p>Studies have shown an increased risk of developing hepatocellular carcinoma in combined oral contraceptive users. However, these cancers are rare in the U.S. There is insufficient data to determine whether POPs increase the risk of developing hepatic neoplasia.</p>

<a id="ID18"></a><a id="s-42232-9"></a>
<h2>Precautions</h2>
<p class="First"><a id="ID19"></a><span class="Bold">1.         General</span></p>
<p>Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases.</p>
<p><span class="Bold">2.         Physical Examination and Follow up</span></p>
<p>It is considered good medical practice for sexually active women using oral contraceptives to have annual history and physical examinations. The physical examination may be deferred until after initiation of oral contraceptives if requested by the woman and judged appropriate by the healthcare professional.</p>
<p><span class="Bold">3.         Carbohydrate and Lipid Metabolism</span></p>
<p>Some users may experience slight deterioration in glucose tolerance, with increases in plasma insulin but women with diabetes mellitus who use progestin-only oral contraceptives do not generally experience changes in their insulin requirements. Nonetheless, prediabetic and diabetic women in particular should be carefully monitored while taking POPs.</p>
<p>Lipid metabolism is occasionally affected in that HDL, HDL2, and apolipoprotein A-I and A-II may be decreased; hepatic lipase may be increased. There is usually no effect on total cholesterol, HDL<span class="Sub">3</span> , LDL, or VLDL.</p>
<p><span class="Bold">4.         Drug Interactions</span></p>
<p>The effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin, carbamazepine, and barbiturates, and the antituberculosis drug rifampin. No significant interaction has been found with broad-spectrum antibiotics.</p>
<p>Herbal products containing St. John's Wort (Hypericum perforatum) may induce hepatic enzymes (cytochrome P450) and p-glycoprotein transporter and may reduce the effectiveness of contraceptive steroids. This may also result in breakthrough bleeding.</p>
<p>Concurrent use of bosentan and norethindrone containing products may result in decreased concentrations of these contraceptive hormones thereby increasing the risk of unintended pregnancy and unscheduled bleeding.</p>
<p><span class="Bold">5.          Interactions with Laboratory Tests</span></p>
<p>The following endocrine tests may be affected by progestin-only oral contraceptive use:</p>
<ul>
<li>Sex hormone-binding globulin (SHBG) concentrations may be decreased.</li>
<li>Thyroxine concentrations may be decreased, due to a decrease in thyroid binding globulin (TBG).</li>
</ul>
<p><a id="ID21"></a><span class="Bold">6.         Carcinogenesis</span></p>
<p>See <span class="Bold"><a href="#ID16">WARNINGS</a></span> .</p>
<p><span class="Bold">7.         Pregnancy</span></p>
<p>Many studies have found no effects on fetal development associated with long-term use of contraceptive doses of oral progestins. The few studies of infant growth and development that have been conducted have not demonstrated significant adverse effects. It is nonetheless prudent to rule out suspected pregnancy before initiating any hormonal contraceptive use.</p>
<p><span class="Bold">8.          Nursing Mothers</span></p>
<p>In general, no adverse effects have been found on breastfeeding performance or on the health, growth, or development of the infant. However, isolated post-marketing cases of decreased milk production have been reported. Small amounts of progestins pass into the breast milk of nursing mothers, resulting in detectable steroid levels in infant plasma.</p>
<p><span class="Bold">9.          Pediatric Use</span></p>
<p>Safety and efficacy of Jencycla tablets have been established in women of reproductive age. Safety and efficacy are expected to be the same for postpubertal adolescents under the age of 16 and for users 16 years and older. Use of this product before menarche is not indicated.</p>
<p><span class="Bold">10.        Fertility Following Discontinuation</span></p>
<p>The limited available data indicate a rapid return of normal ovulation and fertility following discontinuation of progestin-only oral contraceptives.</p>
<p><span class="Bold">11.        Headache</span></p>
<p>The onset or exacerbation of migraine or development of severe headache with focal neurological symptoms which is recurrent or persistent requires discontinuation of progestin-only contraceptives and evaluation of the cause.</p>

<a id="ID22"></a><a id="s-34076-0"></a>
<h2>INFORMATION FOR PATIENTS</h2>
<p class="First"><a id="ID23"></a>1. See <span class="Bold">"<a href="#ID38">DETAILED PATIENT LABELING</a> "</span> for detailed information.</p>
<p>2. Counseling issues</p>
<p>The following points should be discussed with prospective users before prescribing progestin-only oral contraceptives:</p>
<ul class="Disc">
<li>The necessity of taking pills at the same time every day, including throughout all bleeding episodes.</li>
<li>The need to use a backup method such as condom and spermicide for the next 48 hours whenever a progestin-only oral contraceptive is taken 3 or more hours late.</li>
<li>The potential side effects of progestin-only oral contraceptives, particularly menstrual irregularities.</li>
<li>The need to inform the healthcare professional of prolonged episodes of bleeding, amenorrhea or severe abdominal pain.</li>
<li>The importance of using a barrier method in addition to progestin-only oral contraceptives if a woman is at risk of contracting or transmitting STDs/HIV.</li>
</ul>

<a id="ID25"></a><a id="s-34084-4"></a>
<h2>Adverse Reactions</h2>
<p class="First"><a id="ID26"></a>Adverse reactions reported with the use of POPs include:</p>
<ul>
<li>Menstrual irregularity is the most frequently reported side effect.</li>
<li>Frequent and irregular bleeding are common, while long duration of bleeding episodes and amenorrhea are less likely.</li>
<li>Headache, breast tenderness, nausea, and dizziness are increased among progestin-only oral contraceptive users in some studies.</li>
<li>Androgenic side effects such as acne, hirsutism, and weight gain occur rarely.</li>
</ul>
<p><a id="ID93"></a>The following adverse reactions were also reported in clinical trials or during post-marketing experience:</p>
<p><span class="Bold">Gastrointestinal Disorders</span></p>
<p>Vomiting, abdominal pain</p>
<p><span class="Bold">General Disorders and Administration Site Conditions</span></p>
<p>Fatigue, edema</p>
<p><span class="Bold">Psychiatric Disorders</span></p>
<p>Depression, nervousness</p>
<p><span class="Bold">Musculoskeletal and Connective Tissue Disorders</span></p>
<p>Pain in extremity</p>
<p><span class="Bold">Reproductive System and Breast Disorders</span></p>
<p>Genital discharge; breast pain, menstruation delayed, suppressed lactation, vaginal hemorrhage, menorrhagia, withdrawal bleed when product is stopped</p>
<p><span class="Bold">Immune System Disorders</span></p>
<p>Anaphylactic/anaphylactoid reaction, hypersensitivity</p>
<p><span class="Bold">Hepatobiliary Disorders</span></p>
<p>Hepatitis, jaundice cholestatic</p>
<p><span class="Bold">Skin and Subcutaneous Tissue Disorders</span></p>
<p>Alopecia, rash, rash pruritic</p>

<a id="ID28"></a><a id="s-34088-5"></a>
<h2>Overdosage</h2>
<p class="First"><a id="ID29"></a>There have been no reports of serious ill effects from overdosage, including ingestion by children.</p>

<a id="ID30"></a><a id="s-34068-7"></a>
<h2>Jencycla Dosage and Administration</h2>
<p class="First"><a id="ID31"></a>To achieve maximum contraceptive effectiveness, Jencycla must be taken exactly as directed. One tablet is taken every day, at the same time. Administration is continuous, with no interruption between pill packs. See <span class="Bold"><a href="#ID38">DETAILED PATIENT LABELING</a></span> for detailed instruction.</p>

<a id="ID32"></a><a id="s-34069-5"></a>
<h2>How is Jencycla Supplied</h2>
<p class="First"><a id="ID33"></a>Jencycla Tablets containing 0.35 mg of norethindrone, green colored, round, flat face, beveled edge tablets, debossed with "O23" on one side and "LU" on the other side.</p>
<p>Jencycla Tablets are available in a blister (NDC 68180-877-71) containing 28 tablets. Such three blisters are packaged in a carton (NDC 68180-877-73).</p>
<p><span class="Bold">STORAGE</span>: Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg; to 30&deg;C (59&deg; to 86&deg;F) [see USP Controlled Room Temperature].</p>
<p>Keep out of reach of children.</p>

<a id="ID34"></a><a id="s-34093-5"></a>
<h2>REFERENCES</h2>
<p class="First"><a id="ID35"></a>1.   McCann M, and Potter L. Progestin-Only Oral Contraceptives: A Comprehensive Review. Contraception, 50:60 (Suppl. 1), December 1994.</p>
<p>2.   Van Giersbergen PLM, Halabi A, Dingemanse J. Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol. Int J Clin Pharmacol Ther 2006;44(3):113-118.</p>
<p>3.   Truitt ST, Fraser A, Gallo ME, Lopez LM, Grimes DA and Schulz KF. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation (Review). The Cochrane Collaboration. 2007, Issue 3.</p>
<p>4.   Halderman, LD and Nelson AL. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol.; 186 (6):1250-1258.</p>
<p>5.   Ostrea EM, Mantaring III JB, Silvestre MA. Drugs that affect the fetus and newborn infant via the placenta or breast milk. Pediatr Clin N Am; 51(2004): 539-579.</p>
<p>6.   Cooke ID, Back DJ, Shroff NE: Norethisterone concentration in breast milk and infant and maternal plasma during ethynodiol diactetate administration. Contraception 1985; 31:611-21.</p>
<p>7.   2008 USPC Official:12/1/08-4/30/09, USP Monographs: Norethindrone Tablets (page 1 of 5).</p>
<p>Jencycla&trade; is a trademark of Lupin Pharmaceuticals, Inc.</p>
<p>The other brands listed are trademarks of their respective owners and are not trademarks of Lupin Pharmaceuticals, Inc. The makers of these brands are not affiliated with and do not endorse Lupin Pharmaceuticals, Inc. or its products.</p>

<a id="ID36"></a>
<p class="First"><a id="ID37"></a>Distributed by:</p>
<p><span class="Bold">Lupin Pharmaceuticals, Inc.</span></p>
<p>Baltimore, Maryland 21202</p>
<p>United States</p>
<p>Manufactured by:</p>
<p><span class="Bold">Lupin Limited</span></p>
<p>Pithampur (M.P.) - 454 775</p>
<p>INDIA</p>
<p>April 2020</p>

<a id="ID38"></a>
<p class="First"><a id="ID39"></a><span class="Bold">DETAILED PATIENT LABELING</span></p>
<p><span class="Bold">Jencycla&trade;</span></p>
<p><span class="Bold">(norethindrone tablets USP, 0.35 mg)</span></p>
<p><span class="Bold">Rx Only</span></p>
<p><span class="Bold">This product (like all oral contraceptives) is used to prevent pregnancy. It does not protect against HIV infection (AIDS) or other sexually transmitted diseases.</span></p>
<a id="ID40"></a>
<h3>DESCRIPTION</h3>
<p class="First"><a id="ID41"></a><span class="Bold">Jencycla&trade; Tablets</span></p>
<p>Each tablet contains 0.35 mg norethindrone. Inactive ingredients include D&amp;C yellow No. 10, FD&amp;C blue No. 1, lactose anhydrous, magnesium stearate, povidone and sodium starch glycolate.</p>
<p>The chemical name of norethindrone is 17-hydroxy-19-nor-17&alpha;-pregn-4-en-20-yn-3-one. It has a molecular formula of C<span class="Sub">20</span>H<span class="Sub">26</span>O<span class="Sub">2</span> and a molecular weight of 298.4. It has the following structural formula:</p>
<div class="Figure"><img data-lazy-load data-src='https://www.drugs.com/pro/images/e91e7bdd-2984-4332-9b0b-04322792d7f6/c2277aea-d8d0-4c74-8bc5-f3fc386fe8dc-02.jpg' src='/img/pixel.gif' alt="" /></div>
<p><a id="ID83"></a>Jencycla meets USP Dissolution Test 2.</p>

<a id="ID42"></a>
<h3>INTRODUCTION</h3>
<p class="First"><a id="ID43"></a>This leaflet is about birth control pills that contain one hormone, a progestin. Please read this leaflet before you begin to take your pills. It is meant to be used along with talking with your healthcare professional.</p>
<p>Progestin-only pills are often called "POPs" or "the minipill." POPs have less progestin than the combined birth control pill (or "the pill") which contains both an estrogen and a progestin.</p>

<a id="ID44"></a>
<h3>HOW EFFECTIVE ARE POPs?</h3>
<p class="First"><a id="ID45"></a>About 1 in 200 POP users will get pregnant in the first year if they all take POPs perfectly (that is, on time, every day). About 1 in 20 "typical" POP users (including women who are late taking pills or miss pills) gets pregnant in the first year of use. Table 2 will help you compare the efficacy of different methods.</p>
<a id="ID46"></a>
<div class='responsive-table-wrap'><table style="width: 99%; ">
<caption>Table 2: Percentage of Women Experiencing an Unintended Pregnancy During the First Year of Typical Use and the First Year of Perfect Use of Contraception and the Percentage Continuing Use at the End of the First Year. United States.</caption>
<col style="width: 30%; " />
<col style="width: 20%; " />
<col style="width: 23%; " />
<col style="width: 26%; " />
<thead>
<tr class="First">
<td class="Toprule" colspan="1" style="text-align: left; vertical-align: top; "><span class="Bold"><br /></span></td>
<td class="Toprule" colspan="2" style="text-align: center; vertical-align: top; "><span class="Bold">% </span><span class="Bold">of </span><span class="Bold">Women </span><span class="Bold">Experiencing </span><span class="Bold">an</span> <span class="Bold"><br /></span> <span class="Bold">Unintended </span><span class="Bold">Pregnancy </span><span class="Bold">within </span><span class="Bold">the</span> <span class="Bold"><br /></span> <span class="Bold">First </span><span class="Bold">Year </span><span class="Bold">of </span><span class="Bold">Use</span> <span class="Bold"><br /></span></td>
<td class="Toprule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">% </span><span class="Bold">of </span><span class="Bold">Women</span> <span class="Bold"><br /></span> <span class="Bold">Continuing </span><span class="Bold">Use </span><span class="Bold">at</span> <span class="Bold"><br /></span> <span class="Bold">One </span><span class="Bold">Year<span class="Sup">3</span></span> <span class="Bold"><br /></span></td>
</tr>
<tr>
<td colspan="1" style="text-align: left; vertical-align: top; "><span class="Bold">Method</span> <span class="Bold"><br /></span></td>
<td colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">Typical </span><span class="Bold">Use </span><span class="Bold"><span class="Sup">1</span></span> <span class="Bold"><br /></span></td>
<td colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">Perfect </span><span class="Bold">Use<span class="Sup">2</span></span> <span class="Bold"><br /></span></td>
<td colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold"><br /></span></td>
</tr>
<tr class="Last">
<td class="Botrule" colspan="1" style="text-align: left; vertical-align: top; "><span class="Bold">Header</span><span class="Bold">$(</span><span class="Bold">1</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
<td class="Botrule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">(</span><span class="Bold">2</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
<td class="Botrule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">(</span><span class="Bold">3</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
<td class="Botrule" colspan="1" style="text-align: center; vertical-align: top; "><span class="Bold">(</span><span class="Bold">4</span><span class="Bold">)</span> <span class="Bold"><br /></span></td>
</tr>
</thead>
<tfoot>
<tr class="First">
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Adapted from Hatcher et al, 1998, Ref. # 1.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Emergency Contraceptive Pills: Treatment initiated within 72 hours after unprotected intercourse reduces the risk of pregnancy by at least 75%.<span class="Sup">9</span><br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Lactational Amenorrhea Method: LAM is highly effective, temporary method of contraception.<span class="Sup">1</span><span class="Sup">0</span></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote">Source: Trussell J, Contraceptive efficacy. In Hatcher RA, Trussell J, Stewart F, Cates W, Stewart GK, Kowal D, Guest F, Contraceptive Technology: Seventeenth Revised Edition. New York NY: Irvington Publishers, 1998.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">1</span>Among <span class="Italics">typical</span> couples who initiate use of a method (not necessarily for the first time), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">2</span>Among couples who initiate use of a method (not necessarily for the first time) and who use it <span class="Italics">perfectly</span> (both consistently and correctly), the percentage who experience an accidental pregnancy during the first year if they do not stop use for any other reason.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">3</span>Among couples attempting to avoid pregnancy, the percentage who continue to use a method for one year.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">4</span>The percents becoming pregnant in columns (2) and (3) are based on data from populations where contraception is not used and from women who cease using contraception in order to become pregnant. Among such populations, about 89% become pregnant within one year. This estimate was lowered slightly (to 85%) to represent the percent who would become pregnant within one year among women now relying on reversible methods of contraception if they abandoned contraception altogether.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">5</span>Foams, creams, gels, vaginal suppositories, and vaginal film.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">6</span>Cervical mucus (ovulation) method supplemented by calendar in the pre-ovulatory and basal body temperature in the post-ovulatory phases.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">7</span>With spermicidal cream or jelly.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">8</span>Without spermicides.<br /></p>
</td>
</tr>
<tr>
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">9</span>The treatment schedule is one dose within 72 hours after unprotected intercourse, and a second dose 12 hours after the first dose. The Food and Drug Administration has declared the following brands of oral contraceptives to be safe and effective for emergency contraception: Ovral<span class="Sup">&reg;</span> (1 dose is 2 white pills), Alesse<span class="Sup">&reg;</span> (1 dose is 5 pink pills), Nordette<span class="Sup">&reg;</span> or Levlen<span class="Sup">&reg;</span> (1 dose is 2 light-orange pills), Lo/Ovral<span class="Sup">&reg;</span> (1 dose is 4 white pills), Triphasil<span class="Sup">&reg;</span> or Tri-Levlen<span class="Sup">&reg;</span> (1 dose is 4 yellow pills).<br /></p>
</td>
</tr>
<tr class="Last">
<td colspan="4" style="text-align: left; ">
<p class="First Footnote"><span class="Sup">1</span><span class="Sup">0</span>However, to maintain effective protection against pregnancy, another method of contraception must be used as soon as menstruation resumes, the frequency or duration of breastfeeds is reduced, bottle feeds are introduced, or the baby reaches six months of age.<br /></p>
</td>
</tr>
</tfoot>
<tbody>
<tr class="First">
<td class="Toprule" style="text-align: left; vertical-align: top; ">Chance<span class="Sup">4</span><br /></td>
<td class="Toprule" style="text-align: center; vertical-align: top; ">85<br /></td>
<td class="Toprule" style="text-align: center; vertical-align: top; ">85<br /></td>
<td class="Toprule" style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Spermicides<span class="Sup">5</span><br /></td>
<td style="text-align: center; vertical-align: top; ">26<br /></td>
<td style="text-align: center; vertical-align: top; ">6<br /></td>
<td style="text-align: center; vertical-align: top; ">40<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Periodic abstinence<br /></td>
<td style="text-align: center; vertical-align: top; ">25<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">63<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Calendar<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">9<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Ovulation Method<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">3<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Sympto-Thermal<span class="Sup">6</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">2<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Post-Ovulation<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">1<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Cap<span class="Sup">7</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Parous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">40<br /></td>
<td style="text-align: center; vertical-align: top; ">26<br /></td>
<td style="text-align: center; vertical-align: top; ">42<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Nulliparous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">9<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Sponge<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Parous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">40<br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">42<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Nulliparous Women<br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">9<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Diaphragm<span class="Sup">7</span><br /></td>
<td style="text-align: center; vertical-align: top; ">20<br /></td>
<td style="text-align: center; vertical-align: top; ">6<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Withdrawal<br /></td>
<td style="text-align: center; vertical-align: top; ">19<br /></td>
<td style="text-align: center; vertical-align: top; ">4<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Condom<span class="Sup">8</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Female (Reality<span class="Sup">&reg;</span>)<br /></td>
<td style="text-align: center; vertical-align: top; ">21<br /></td>
<td style="text-align: center; vertical-align: top; ">5<br /></td>
<td style="text-align: center; vertical-align: top; ">56<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Male<br /></td>
<td style="text-align: center; vertical-align: top; ">14<br /></td>
<td style="text-align: center; vertical-align: top; ">3<br /></td>
<td style="text-align: center; vertical-align: top; ">61<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Pill<br /></td>
<td style="text-align: center; vertical-align: top; ">5<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">71<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Progestin Only<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">0.5<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Combined<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; ">0.1<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">IUD<br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Progesterone T<br /></td>
<td style="text-align: center; vertical-align: top; ">2.0<br /></td>
<td style="text-align: center; vertical-align: top; ">1.5<br /></td>
<td style="text-align: center; vertical-align: top; ">81<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     Copper T380A<br /></td>
<td style="text-align: center; vertical-align: top; ">0.8<br /></td>
<td style="text-align: center; vertical-align: top; ">0.6<br /></td>
<td style="text-align: center; vertical-align: top; ">78<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">     LNg 20<br /></td>
<td style="text-align: center; vertical-align: top; ">0.1<br /></td>
<td style="text-align: center; vertical-align: top; ">0.1<br /></td>
<td style="text-align: center; vertical-align: top; ">81<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Depo-Provera<span class="Sup">&reg;</span><br /></td>
<td style="text-align: center; vertical-align: top; ">0.3<br /></td>
<td style="text-align: center; vertical-align: top; ">0.3<br /></td>
<td style="text-align: center; vertical-align: top; ">70<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Norplant<span class="Sup">&reg;</span> and<br /></td>
<td style="text-align: center; vertical-align: top; ">0.05<br /></td>
<td style="text-align: center; vertical-align: top; ">0.05<br /></td>
<td style="text-align: center; vertical-align: top; ">88<br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Norplant-2<span class="Sup">&reg;</span><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
<td style="text-align: center; vertical-align: top; "><br /></td>
</tr>
<tr>
<td style="text-align: left; vertical-align: top; ">Female Sterilization<br /></td>
<td style="text-align: center; vertical-align: top; ">0.5<br /></td>
<td style="text-align: center; vertical-align: top; ">0.5<br /></td>
<td style="text-align: center; vertical-align: top; ">100<br /></td>
</tr>
<tr class="Last">
<td class="Botrule" style="text-align: left; vertical-align: top; ">Male Sterilization<br /></td>
<td class="Botrule" style="text-align: center; vertical-align: top; ">0.15<br /></td>
<td class="Botrule" style="text-align: center; vertical-align: top; ">0.10<br /></td>
<td class="Botrule" style="text-align: center; vertical-align: top; ">100<br /></td>
</tr>
</tbody>
</table></div>

<a id="ID47"></a>
<p class="First"><a id="ID48"></a><span class="Bold"><span class="Italics">Jencycla Tablets have not been studied for and are not indicated for use in emergency contraception.</span></span></p>
<p><span class="Bold">HOW DO POPs WORK?</span></p>
<p>POPs can prevent pregnancy in different ways including:</p>
<ul>
<li>They make the cervical mucus at the entrance to the womb (the uterus) too thick for the sperm to get through to the egg.</li>
<li>They prevent ovulation (release of the egg from the ovary) in about half of the cycles.</li>
<li>They also affect other hormones, the fallopian tubes and the lining of the uterus.</li>
</ul>
<p><a id="ID50"></a><span class="Bold">YOU SHOULD NOT TAKE POPs</span></p>
<ul class="Disc">
<li>If there is any chance you may be pregnant.</li>
<li>If you have breast cancer.</li>
<li>If you have bleeding between your periods that has not been diagnosed.</li>
<li>If you are taking certain drugs for epilepsy (seizures) or for TB, or medicine for pulmonary hypertension or certain herbal products. (See "<span class="Bold">Using POPs with Other Medicines</span> " below.)</li>
<li>If you are hypersensitive, or allergic, to any component of this product.</li>
<li>If you have liver tumors, either benign or cancerous.</li>
<li>If you have acute liver disease.</li>
</ul>
<p><a id="ID52"></a><span class="Bold">RISKS OF TAKING POPs</span></p>
<p>Cigarette smoking greatly increases the possibility of suffering heart attacks and strokes. Women who use oral contraceptives are strongly advised not to smoke.</p>
<p><span class="Bold">WARNING:</span></p>
<p>If you have sudden or severe pain in your lower abdomen or stomach area, you may have an ectopic pregnancy or an ovarian cyst. If this happens, you should contact your healthcare professional immediately.</p>
<p><span class="Bold">Ectopic Pregnancy</span></p>
<p>An ectopic pregnancy is a pregnancy outside the womb. Because POPs protect against pregnancy, the chance of having a pregnancy outside the womb is very low. If you do get pregnant while taking POPs, you have a slightly higher chance that the pregnancy will be ectopic than do users of some other birth control methods.</p>
<p><span class="Bold">Ovarian Cysts</span></p>
<p>These cysts are small sacs of fluid in the ovary. They are more common among POP users than among users of most other birth control methods. They usually disappear without treatment and rarely cause problems.</p>
<p><span class="Bold">Cancer Of The Reproductive Organs And Breasts</span></p>
<p>Some studies in women who use combined oral contraceptives that contain both estrogen and a progestin have reported an increase in the risk of developing breast cancer, particularly at a younger age and apparently related to duration of use. There is insufficient data to determine whether the use of POPs similarly increases this risk.</p>
<p>A meta-analysis of 54 studies found a small increase in the frequency of having breast cancer diagnosed for women who were currently using combined oral contraceptives or had used them within the past ten years. This increase in the frequency of breast cancer diagnosis, within ten years of stopping use, was generally accounted for by cancers localized to the breast. There was no increase in the frequency of having breast cancer diagnosed ten or more years after cessation of use.</p>
<p>Some studies have found an increase in the incidence of cancer of the cervix in women who use oral contraceptives. However, this finding may be related to factors other than the use of oral contraceptives and there is insufficient data to determine whether the use of POPs increases the risk of developing cancer of the cervix.</p>
<p><span class="Bold">Liver Tumors</span></p>
<p>In rare cases, combined oral contraceptives can cause benign but dangerous liver tumors. These benign liver tumors can rupture and cause fatal internal bleeding. In addition, some studies report an increased risk of developing liver cancer among women who use combined oral contraceptives. However, liver cancers are rare. There is insufficient data to determine whether POPs increase the risk of liver tumors.</p>
<p><span class="Bold">Diabetic Women</span></p>
<p>Diabetic women taking POPs do not generally require changes in the amount of insulin they are taking. However, your healthcare professional may monitor you more closely under these conditions.</p>

<a id="ID53"></a>
<p class="First"><a id="ID54"></a><span class="Bold">SEXUALLY TRANSMITTED DISEASES (STDs)</span></p>
<p><span class="Bold">WARNING: POPs do not protect against getting or giving someone HIV (AIDS) or any other STD, such as chlamydia, gonorrhea, genital warts or herpes.</span></p>
<p><span class="Bold">SIDE EFFECTS</span></p>
<p><span class="Bold">Irregular Bleeding:</span></p>
<p>The most common side effect of POPs is a change in menstrual bleeding. Your periods may be either early or late, and you may have some spotting between periods. Taking pills late or missing pills can result in some spotting or bleeding.</p>
<p><span class="Bold">Other Side Effects:</span></p>
<p>Less common side effects include headaches, tender breasts, nausea, vomiting, dizziness, and fatigue. Depression, nervousness, leg pain, vaginal discharge, fluid retention, allergic reactions, jaundice or a yellowing of the skin or eyeballs, loss of scalp hair, rash/itchy rash, weight gain, acne and extra hair on your face and body have been reported, but are rare.</p>
<p>If you are concerned about any of these side effects, check with your healthcare professional.</p>
<p><span class="Bold">USING POPs WITH OTHER MEDICINES</span></p>
<p>Before taking a POP, inform your healthcare professional of any other medication, including over-the-counter medicine, that you may be taking.</p>
<p>These medicines can make POPs less effective:</p>
<p>Medicines for seizures such as:</p>
<ul>
<li>Phenytoin (Dilantin<span class="Sup">&reg;</span>)</li>
<li>Carbamazepine (Tegretol<span class="Sup">&reg;</span>)</li>
<li>Phenobarbital</li>
</ul>
<p><a id="ID75"></a>Medicine for TB:</p>
<ul class="Disc">
<li>Rifampin (Rifampicin)</li>
</ul>
<p><a id="ID94"></a>Medicine for pulmonary hypertension such as:</p>
<ul class="Disc">
<li>Bosentan (Tracleer<span class="Sup">&reg;</span>)</li>
</ul>
<p><a id="ID96"></a>Herbal products such as:</p>
<ul class="Disc">
<li>St. John's Wort</li>
</ul>
<p><a id="ID56"></a>Before you begin taking any new medicines be sure your healthcare professional knows you are taking a progestin-only birth control pill.</p>

<a id="ID57"></a>
<p class="First"><a id="ID58"></a><span class="Bold">HOW TO TAKE POPs</span></p>
<p><span class="Bold Underline">IMPORTANT POINTS TO REMEMBER</span></p>
<ul>
<li>POPs must be taken at the same time every day, so choose a time and then take the pill at that same time every day. Every time you take a pill late, and especially if you miss a pill, you are more likely to get pregnant.</li>
<li>Start the next pack the day after the last pack is finished. There is no break between packs. Always have your next pack of pills ready.</li>
<li>You may have some menstrual spotting between periods. Do not stop taking your pills if this happens.</li>
<li>If you vomit soon after taking a pill, use a backup method (such as a condom and/or a spermicide) for 48 hours.</li>
<li>If you want to stop taking POPs, you can do so at any time, but, if you remain sexually active and don&rsquo;t wish to become pregnant, be certain to use another birth control method.</li>
<li>If you are not sure about how to take POPs, ask your healthcare professional.</li>
</ul>
<p><a id="ID60"></a><span class="Bold Underline">STARTING POPs</span></p>
<ul>
<li>It&rsquo;s best to take your first POP on the first day of your menstrual period.</li>
<li>If you decide to take your first POP on another day, use a backup method (such as a condom and/or a spermicide) every time you have sex during the next 48 hours.</li>
<li>If you have had a miscarriage or an abortion, you can start POPs the next day.</li>
<li>Find:</li>
</ul>
<p><a id="ID84"></a>        &bull;     Where on the pack to start taking pills,</p>
<p>        &bull;     In what order to take the pills (follow the arrows), and</p>
<p>        &bull;     The week numbers as shown in the picture below:</p>
<div class="Figure"><img data-lazy-load data-src='https://www.drugs.com/pro/images/e91e7bdd-2984-4332-9b0b-04322792d7f6/c2277aea-d8d0-4c74-8bc5-f3fc386fe8dc-03.jpg' src='/img/pixel.gif' alt="" /></div>
<p><a id="ID62"></a><span class="Bold Underline">IF YOU ARE LATE OR MISS TAKING YOUR POPs</span></p>
<ul>
<li>If you are more than 3 hours late or you miss one or more POPs:</li>
</ul>
<p><a id="ID64"></a>1) <span class="Bold">TAKE</span> a missed pill as soon as you remember that you missed it,</p>
<p>2) <span class="Bold">THEN</span> go back to taking POPs at your regular time,</p>
<p>3) <span class="Bold">BUT</span> be sure to use a backup method (such as a condom and/or a spermicide) every time you have sex for the next 48 hours.</p>
<ul>
<li>If you are not sure what to do about the pills you have missed, keep taking POPs and use a backup method until you can talk to your healthcare professional.</li>
</ul>
<p><a id="ID78"></a><span class="Bold Underline">IF YOU ARE BREASTFEEDING</span></p>
<ul>
<li>If you are fully breastfeeding (not giving your baby any food or formula), you may start your pills 6 weeks after delivery.</li>
<li>If you are partially breastfeeding (giving your baby some food or formula), you should start taking pills by 3 weeks after delivery.</li>
</ul>
<p><a id="ID66"></a><span class="Bold Underline">IF YOU ARE SWITCHING PILLS</span></p>
<ul>
<li>If you are switching from the combined pills to POPs, take the first POP the day after you finish the last active combined pill. Do not take any of the 7 inactive pills from the combined pill pack. You should know that many women have irregular periods after switching to POPs, but this is normal and to be expected.</li>
<li>If you are switching from POPs to the combined pills, take the first active combined pill on the first day of your period, even if your POPs pack is not finished.</li>
<li>If you switch to another brand of POPs, start the new brand anytime.</li>
<li>If you are breastfeeding, you can switch to another method of birth control at any time, except do not switch to the combined pills until you stop breastfeeding or at least until 6 months after delivery.</li>
</ul>
<p><a id="ID68"></a><span class="Bold">PREGNANCY WHILE ON THE PILL</span></p>
<p>If you think you are pregnant, contact your healthcare professional. Even though research has shown that POPs do not cause harm to the unborn baby, it is always best not to take any drugs or medicines that you don&rsquo;t need when you are pregnant.</p>
<p>You should get a pregnancy test:</p>
<ul>
<li>If your period is late and you took one or more pills late or missed taking them and had sex without a backup method.</li>
<li>Anytime it has been more than 45 days since the beginning of your last period.</li>
</ul>
<p><a id="ID70"></a><span class="Bold">WILL POPs AFFECT YOUR ABILITY TO GET PREGNANT LATER?</span></p>
<p>If you want to become pregnant, simply stop taking POPs. POPs will not delay your ability to get pregnant.</p>
<p><span class="Bold">BREASTFEEDING</span></p>
<p>If you are breastfeeding, POPs will not affect the quality or amount of your breast milk or the health of your nursing baby. However, isolated cases of decreased milk production have been reported.</p>
<p><span class="Bold">OVERDOSE</span></p>
<p>No serious problems have been reported when many pills were taken by accident, even by a small child, so there is usually no reason to treat an overdose.</p>
<p><span class="Bold">OTHER QUESTIONS OR CONCERNS</span></p>
<p>If you have any questions or concerns, check with your healthcare professional. You can also ask for the more detailed "Professional Labeling" written for doctors and other healthcare professionals.</p>
<p><span class="Bold">HOW TO STORE YOUR POPs</span></p>
<p>Store at 25&deg;C (77&deg;F); excursions permitted to 15&deg; to 30&deg;C (59&deg; to 86&deg;F).</p>
<p>Keep out of reach of children.</p>
<p>Jencycla&trade; is a trademark of Lupin Pharmaceuticals, Inc.</p>
<p>The other brands listed are trademarks of their respective owners and are not trademarks of Lupin Pharmaceuticals, Inc. The makers of these brands are not affiliated with and do not endorse Lupin Pharmaceuticals, Inc. or its products.</p>

<a id="ID71"></a>
<p class="First"><a id="ID72"></a>Distributed by:</p>
<p><span class="Bold">Lupin Pharmaceuticals, Inc.</span></p>
<p>Baltimore, Maryland 21202</p>
<p>United States</p>
<p>Manufactured by:</p>
<p><span class="Bold">Lupin Limited</span></p>
<p>Pithampur (M.P.) - 454 775</p>
<p>INDIA</p>
<p>Revised: April 2020                                                                 ID#: 261895</p>


<a id="ID86"></a>
<h2>PACKAGE LABEL.PRINCIPAL DISPLAY PANEL</h2>
<p class="First"><a id="ID87"></a><span class="Bold">Jencycla&trade;</span></p>
<p>(norethindrone tablets USP)</p>
<p>0.35 mg</p>
<p>Carton Pack:</p>
<p>NDC: 68180-877-73</p>
<p>3 Blisters of 28 Tablets Each</p>
<div class="Figure"><img data-lazy-load data-src='https://www.drugs.com/pro/images/e91e7bdd-2984-4332-9b0b-04322792d7f6/c2277aea-d8d0-4c74-8bc5-f3fc386fe8dc-04.jpg' src='/img/pixel.gif' alt="" /></div>
<p><a id="ID89"></a><span class="Bold">Jencycla&trade;</span></p>
<p>(norethindrone tablets USP)</p>
<p>0.35 mg</p>
<p>Blister Pack:</p>
<p>NDC: 68180-877-71</p>
<p>1 Blister of 28 Tablets</p>
<div class="Figure"><img data-lazy-load data-src='https://www.drugs.com/pro/images/e91e7bdd-2984-4332-9b0b-04322792d7f6/c2277aea-d8d0-4c74-8bc5-f3fc386fe8dc-05.jpg' src='/img/pixel.gif' alt="" /></div>


<div class="DataElementsTables">
<div class='responsive-table-wrap'><table class="contentTablePetite" style="width: 100%; ">
<tbody>
<tr>
<td class="contentTableTitle"><strong>Jencycla </strong><br />
<span class="contentTableReg">norethindrone tablet</span></td>
</tr>
<tr>
<td>
<div class='responsive-table-wrap'><table class="formTablePetite" style="width: 100%; ">
<tr>
<td colspan="4" class="formHeadingTitle">Product Information</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:68180-877</td>
</tr>
<tr class="formTableRow">
<td class="formLabel" style="width: 30%; ">Route of Administration</td>
<td class="formItem">ORAL</td>
<td class="formLabel" style="width: 30%; ">DEA Schedule</td>
<td class="formItem">    </td>
</tr>
</table></div>
</td>
</tr>
<tr>
<td>
<div class='responsive-table-wrap'><table class="formTablePetite" style="width: 100%; ">
<tr>
<td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td>
</tr>
<tr>
<td class="formTitle">Ingredient Name</td>
<td class="formTitle">Basis of Strength</td>
<td class="formTitle">Strength</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>NORETHINDRONE</strong> (NORETHINDRONE)</td>
<td class="formItem">NORETHINDRONE</td>
<td class="formItem">0.35 mg</td>
</tr>
</table></div>
</td>
</tr>
<tr>
<td>
<div class='responsive-table-wrap'><table class="formTablePetite" style="width: 100%; ">
<tr>
<td colspan="2" class="formHeadingTitle">Inactive Ingredients</td>
</tr>
<tr>
<td class="formTitle">Ingredient Name</td>
<td class="formTitle">Strength</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ANHYDROUS LACTOSE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>D&amp;C YELLOW NO. 10</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>FD&amp;C BLUE NO. 1</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM STARCH GLYCOLATE TYPE A POTATO</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>POVIDONE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
</table></div>
</td>
</tr>
<tr>
<td>
<div class='responsive-table-wrap'><table class="formTablePetite" style="width: 100%; ">
<tr>
<td colspan="4" class="formHeadingTitle">Product Characteristics</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">GREEN (green)</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND (round)</td>
<td class="formLabel">Size</td>
<td class="formItem">6mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">LU;O23</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></div>
</td>
</tr>
<tr>
<td>
<div class='responsive-table-wrap'><table class="formTablePetite" style="width: 100%; ">
<tr>
<td colspan="4" class="formHeadingTitle">Packaging</td>
</tr>
<tr>
<td class="formTitle" style="width: 1px; ">#</td>
<td class="formTitle">Item Code</td>
<td class="formTitle">Package Description</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>1</strong></td>
<td class="formItem">NDC:68180-877-73</td>
<td class="formItem">1 BLISTER PACK in 1 CARTON</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>1</strong></td>
<td class="formItem">NDC:68180-877-71</td>
<td class="formItem">28 TABLET in 1 BLISTER PACK</td>
</tr>
</table></div>
</td>
</tr>
<tr>
<td></td>
</tr>
<tr>
<td class="normalizer">
<div class='responsive-table-wrap'><table class="formTableMorePetite" style="width: 100%; ">
<tr>
<td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td>
</tr>
<tr>
<td class="formTitle">Marketing Category</td>
<td class="formTitle">Application Number or Monograph Citation</td>
<td class="formTitle">Marketing Start Date</td>
<td class="formTitle">Marketing End Date</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA091323</td>
<td class="formItem">07/07/2020</td>
<td class="formItem"></td>
</tr>
</table></div>
</td>
</tr>
</tbody>
</table></div>
<div class='responsive-table-wrap'><table class="formTableMorePetite" style="width: 100%; ">
<tr>
<td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Labeler - </span>Lupin Pharmaceuticals, Inc. (089153071)</td>
</tr>
</table></div>
<div class='responsive-table-wrap'><table class="formTableMorePetite" style="width: 100%; ">
<tr>
<td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Registrant - </span>LUPIN LIMITED (675923163)</td>
</tr>
</table></div>
<div class='responsive-table-wrap'><table class="formTableMorePetite" style="width: 100%; ">
<tr>
<td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td>
</tr>
<tr>
<td class="formTitle">Name</td>
<td class="formTitle">Address</td>
<td class="formTitle">ID/FEI</td>
<td class="formTitle">Operations</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">LUPIN LIMITED</td>
<td class="formItem"></td>
<td class="formItem">650582310</td>
<td class="formItem">MANUFACTURE(68180-877)</td>
</tr>
</table></div>
</div>

 
<div class="DistributorName">Lupin Pharmaceuticals, Inc.</div>
<div id='moreResources' class='more-resources'>
<h2>More about Jencycla (norethindrone)</h2>
<ul class='more-resources-list more-resources-list-general'>
<li><a href='/sfx/jencycla-side-effects.html'>Side Effects</a></li>
<li><a href='/pregnancy/norethindrone.html'>During Pregnancy</a> or 
<a href='/breastfeeding/norethindrone.html'>Breastfeeding</a></li>
<li><a href='/dosage/jencycla.html' data-action='drug-dosage-disambiguation' data-ddc_id='1730' data-brand_id='16155'>Dosage Information</a></li>
<li><a href='/jencycla-images.html'>Drug Images</a></li>
<li><a href='/drug-interactions/norethindrone,jencycla.html'>Drug Interactions</a></li>
<li><a href='/price-guide/jencycla'>Pricing &amp; Coupons</a></li>
<li><a href='/comments/norethindrone/jencycla.html'>40 Reviews</a></li>
<li><a href='/drug-class/contraceptives.html'>Drug class: contraceptives</a></li>
</ul>
<h3>Consumer resources</h3>
<ul class='more-resources-list more-resources-list-consumer'>
<li><a href='/cdi/jencycla.html'>Patient Information</a></li>
</ul>
<h3>Professional resources</h3>
<ul class='more-resources-list more-resources-list-professional'>
<li><a href='/monograph/norethindrone.html'>Prescribing Information</a></li>
<li><a href='/pro/norethindrone-tablets.html'>Norethindrone Tablets <span>(FDA)</span></a></li>
</ul>
<dl class='more-resources-other-brands more-resources-other-brands-professional'><dt>Other brands</dt><dd><a href='/pro/aygestin.html'>Aygestin</a>, <a href='/pro/camila.html'>Camila</a>, <a href='/pro/ortho-micronor.html'>Ortho Micronor</a>, <a href='/pro/errin.html'>Errin</a>, <a href='#' class='more-resources-more-toggle' data-more-toggle data-more-config-id='list-data-other-brands-professional' rel='nofollow'>... +12 more</a></dd></dl>
<h3>Related treatment guides</h3>
<ul class='more-resources-list more-resources-list-conditions'>
<li><a href='/health-guide/endometriosis.html' data-send-data='/js/async/drug-condition-log.php' data-type='drug-condition' data-ddc_id='1730' data-brand_name_id='16155' data-condition_id='607'>Endometriosis</a></li>
<li><a href='/condition/abnormal-uterine-bleeding.html' data-send-data='/js/async/drug-condition-log.php' data-type='drug-condition' data-ddc_id='1730' data-brand_name_id='16155' data-condition_id='3'>Abnormal Uterine Bleeding</a></li>
<li><a href='/health-guide/amenorrhea.html' data-send-data='/js/async/drug-condition-log.php' data-type='drug-condition' data-ddc_id='1730' data-brand_name_id='16155' data-condition_id='498'>Amenorrhea</a></li>
<li><a href='/condition/contraception.html' data-send-data='/js/async/drug-condition-log.php' data-type='drug-condition' data-ddc_id='1730' data-brand_name_id='16155' data-condition_id='567'>Birth Control</a></li>
</ul>
</div>
<p class='ddc-disclaimer-link'><a href='/support/disclaimer-pro.html'>Medical Disclaimer</a></p>

</div>
<!-- google_ad_section_end -->

</div>


<div id='sidebar' class='ddc-clearfix'>
<div class='ddc-status-info'>
	<h3 class='ddc-status-info-title'>Drug Status</h3>
	<div class="ddc-box">
		<div class="ddc-accordion" role="presentation">

			
		<div class='ddc-accordion-section'>
			<div class='ddc-accordion-header ddc-mg-0'  data-static='true'>
				<h4 class='ddc-accordion-heading'>Availability
					<span class='ddc-accordion-summary ddc-display-block ddc-mg-0'>Prescription only</span>
					<span class='ddc-status-icon drugInfoRx1'>Rx</span>
					</h4>
			</div>
			
		</div>
		
		<div class='ddc-accordion-section'>
			<div class='ddc-accordion-header ddc-mg-0'  data-static='true'>
				<h4 class='ddc-accordion-heading'><a href='/pregnancy/norethindrone.html'>Pregnancy &amp; Lactation
					<span class='ddc-accordion-summary ddc-display-block ddc-mg-0'>Risk data available</span>
					<span class='ddc-status-icon drugInfoPregMultiple'><svg class='ddc-icon ddc-icon-pregnancy' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M10.62 7.03c.38-1.4 2.43-2.17 3.3-1.27.2.2.33.5.48.98l.11.36.12.42.06.23.29 1.13.09.34.02.08c.08.17.48.42 1.19.69l.98.34.26.1.3.14a2.7 2.7 0 011.42 2.99c-.2 1.2-.9 2.25-2.24 3.68a8.56 8.56 0 01-5.62 2.44c-2.35.17-4.48-1.02-5.23-2.63a5.89 5.89 0 01-.24-.6l-.11-.35-.12-.42-.26-.94-.09-.32-.08-.27-.08-.2-.07-.16a.57.57 0 00-.08-.14H5l-.1.01-.15.02-.62.13c-.35.06-.56.07-.83 0-.87-.18-1.3-.67-1.5-1.45a2.28 2.28 0 011-2.36l.16-.1.1-.06.18-.1.22-.1.24-.11.45-.18.36-.14.93-.34c1.67-.6 2.7-.28 3.44.85a3 3 0 01.51 1.27l.07.46.04.18c.07.33.37.5.8.5.2 0 .77-.24 1.14-.44l.07-.05-.1-.15-.17-.27-.07-.12a1 1 0 01-.06-.19l-.02-.08-.24-.9-.1-.48c-.06-.26-.1-.5-.14-.74-.08-.59-.1-1.1-.02-1.54zm2.24-.14h-.02c-.09 0-.19.03-.28.07-.28.1-.46.29-.5.47-.04.26-.03.63.03 1.07.05.3.11.63.2.98l.27 1.05c0-.01 0-.01 0 0l.17.23.17.26c.08.14.14.26.19.4a1 1 0 01-.17 1.01c-.42.5-1.88 1.2-2.62 1.2-1.06 0-2.03-.56-2.27-1.7a8.8 8.8 0 01-.08-.41l-.07-.43-.02-.1a1.6 1.6 0 00-.23-.44c-.36-.54-.65-.63-1.69-.26l-.66.24-.66.25-.37.15-.2.08-.16.09-.14.08-.2.12c-.2.14-.34.51-.3.69.08.27.1.3.36.36h.16l.08-.02.54-.1c.78-.15 1.26-.1 1.73.4.26.28.43.63.62 1.26l.12.41.31 1.16.1.33.1.28.04.13.1.22c.48 1.03 2.02 1.9 3.76 1.77a7.08 7.08 0 004.63-1.97c1.15-1.23 1.72-2.1 1.86-2.92.12-.68-.12-1.13-.64-1.4a.6.6 0 00-.04-.03l-.16-.06-.35-.13-.8-.28-.24-.1c-.96-.37-1.55-.78-1.82-1.43l-.03-.07-.05-.17-.06-.22-.44-1.7-.1-.35-.1-.27-.07-.2zM19 3.25a3.25 3.25 0 110 6.5 3.25 3.25 0 010-6.5zm0 1.5a1.75 1.75 0 100 3.5 1.75 1.75 0 000-3.5z' /></svg></span>
					</a></h4>
			</div>
			
		</div>
		
		<div class='ddc-accordion-section'>
			<div class='ddc-accordion-header ddc-mg-0' aria-expanded='false' id='accordion-heading-2' role='button' tabindex='0' aria-controls='accordion-content-2' data-type='csa' data-box-info-module='drug' data-id='N' data-ddc_id='0' data-brand_name_id='0'>
				<h4 class='ddc-accordion-heading'>CSA Schedule*
					<span class='ddc-accordion-summary ddc-display-block ddc-mg-0'>Not a controlled drug</span>
					<span class='ddc-status-icon drugInfoCSAN'>N/A</span>
					<svg class='ddc-icon ddc-icon-accordion-expand' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z' /></svg></h4>
			</div>
			
<div class='ddc-status-info-content ddc-accordion-content ddc-text-wordbreak' id='accordion-content-2' aria-labelledby='accordion-heading-2'>
	<div class='ddc-text-color-secondary ddc-text-size-small' aria-live='polite'>
	  <p>Loading...</p>
	</div>
</div>
		</div>
		
		<div class='ddc-accordion-section'>
			<div class='ddc-accordion-header ddc-mg-0' aria-expanded='false' id='accordion-heading-3' role='button' tabindex='0' aria-controls='accordion-content-3' data-type='approval' data-box-info-module='drug' data-id='/pro/jencycla.html' data-ddc_id='1730' data-brand_name_id='16155'>
				<h4 class='ddc-accordion-heading'>Approval History
					<span class='ddc-accordion-summary ddc-display-block ddc-mg-0'>Drug history at FDA</span>
					<span class='ddc-status-icon drugInfoDateCal'><svg class='ddc-icon ddc-icon-history' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M8.75 2.25v1h6.5v-1h1.5v1H19c.92 0 1.67.7 1.74 1.6l.01.15v14c0 .97-.78 1.75-1.75 1.75H5c-.97 0-1.75-.78-1.75-1.75V5c0-.97.78-1.75 1.75-1.75h2.25v-1h1.5zm10.5 6.5H4.75V19c0 .12.08.22.2.24l.05.01h14c.14 0 .25-.11.25-.25V8.75zm-12-4H5a.25.25 0 00-.25.25v2.25h14.5V5a.25.25 0 00-.2-.24L19 4.75h-2.25v1h-1.5v-1h-6.5v1h-1.5v-1z' /></svg></span>
					<svg class='ddc-icon ddc-icon-accordion-expand' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z' /></svg></h4>
			</div>
			
<div class='ddc-status-info-content ddc-accordion-content ddc-text-wordbreak' id='accordion-content-3' aria-labelledby='accordion-heading-3'>
	<div class='ddc-text-color-secondary ddc-text-size-small' aria-live='polite'>
	  <p>Loading...</p>
	</div>
</div>
		</div>
				</div>
	</div>
</div>
	<div class="sideBox sideBoxRelatedDrugs">
	<div class="sideBoxHead">
		<div class="sideBoxTitle">Related Drugs</div>
	</div>
	<div class="sideBoxContent">
<p><a href="/premarin.html">Premarin</a>, <a href="/progesterone.html">progesterone</a>, <a href="/mtm/norethindrone.html">norethindrone</a>, <a href="/medroxyprogesterone.html">medroxyprogesterone</a>, <a href="/mtm/megestrol.html">megestrol</a>, <a href="/mtm/levonorgestrel-emergency-contraceptive.html">levonorgestrel</a>, <a href="/depo-provera.html">Depo-Provera</a>, <a href="/mtm/sprintec.html">Sprintec</a>, <a href="/mirena.html">Mirena</a>, <a href="/mtm/provera.html">Provera</a></p>	</div>
</div>
<div class='sideBox sideBoxUserReviews'>
	<div class='sideBoxContent ddc-clearfix'>
		<div class='sideBoxTitle'>User Reviews &amp; Ratings</div>
		<div class='ddc-rating-summary'>

<div><b>4.5</b><span class='ddc-text-color-secondary'> / 10</span></div>
<div class='ddc-rating-bar'><span style='width: 45.1%;'></span></div>
<em><a href='/comments/norethindrone/jencycla.html'>40 Reviews</a></em>
		</div>
	</div>
</div>
<div class="sideBox sideBoxDrugImage">
	<div class="sideBoxHead">
		<div class="sideBoxTitle">Images</div>
	</div>
	<div class="sideBoxContent">
		<div id='drug-imprint-primary' class="drugImage">
			<div class="drugImageHolder">
				<a href="/imprints/lu-o23-20867.html" title="View larger image">
					<img alt="Pill Imprint LU O23 (Jencycla 0.35 mg)" src='/img/pixel.gif' width='300' height='225' data-lazy-load data-src='https://www.drugs.com/images/pills/custom/pill20867-1/jencycla.jpg'>
					<noscript><img alt="Pill Imprint LU O23 (Jencycla 0.35 mg)" src='https://www.drugs.com/images/pills/custom/pill20867-1/jencycla.jpg'></noscript>
				</a>
			</div>
			<div class="drugImageText">
				Jencycla 0.35 mg (LU O23)			</div>
		</div>

		<nav class='drugImageNav' aria-label="Browse pill images">
<a href='#' role='button' data-drug-imprint-image data-url='/imprints/lu-o23-20867.html' data-label='Jencycla 0.35 mg (LU O23)'><img alt='Jencycla 0.35 mg (LU O23)' src='/img/pixel.gif' width='100' height='75' data-lazy-load data-src='https://www.drugs.com/images/pills/custom/pill20867-1/jencycla.jpg'></a>
<a class='more' href='/jencycla-images.html' role='button'>View larger images</a>
		</nav>
	</div>
</div>
	<div id='sideBoxStackedAdWrap-1' class='sideBoxStackedAdWrap'>
		<div id='sideBoxStackedAd-1' class='sideBox sideBoxFixedAd300 sideBoxStackedAd'>
			<div id='drugs-drugs-2' class='display-ad display-ad-300x600'>
<script>
var ehs_ad_called = ++ehs_ad_called || 1;
</script>
</div>
<script src='//ads.ehealthcaresolutions.com/a/?adid=drugs-drugs-2&slotid=2&url=www.drugs.com%2Fpro%2Fjencycla.html&size=300x250,300x600&vpos=t&hpos=r&site=ehs.pro.drugs.drugs&drg=norethindrone&drg=Jencycla&drc=contraceptives&drc=progestins&dra=1' defer></script>
		</div>
	</div>
	</div>

</div>
</main>

<footer id='footer' class='footer ddc-clearfix'>
	<section class="footer-feature">
		<div class="container">
			<div class="promo-content" data-lazy-load data-background-image='/img/apps/promo-uberapp.png'>
				<h2 class='ddc-mgt-0 ddc-text-weight-bold'>Drugs.com <span>Mobile Apps</span></h2>
				<p>The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.</p>
				<a href="/apps/" class="ddc-btn" onclick="ga('send', { hitType: 'event', eventCategory: 'App Promo', eventAction: 'Footer', eventLabel: 'Explore Apps' });">Explore Apps</a>
			</div>
		</div>
	</section>

	<div class="container">
		<div class="footer-sections">
			<div class='footer-logomark' data-lazy-load data-background-image='/img/logo/drugscom-logo.png'></div>

			<div class="footer-content-links">
				<section class="footer-section">
					<h2 class='ddc-mgt-0'>Support</h2>
					<ul class='ddc-list-unstyled ddc-mg-0'>
						<li><a href='/support/'>Help Center</a></li>
						<li><a href='/sitemap.html'>Sitemap</a></li>
						<li><a href="/support/contact.html">Contact Us</a></li>
					</ul>
				</section>

				<section class="footer-section">
					<h2 class='ddc-mgt-0'>About</h2>
					<ul class='ddc-list-unstyled ddc-mg-0'>
						<li><a href="/support/about.html">About Drugs.com</a></li>
						<li><a href="/support/advertising.html">Advertising Policy</a></li>
						<li><a href="/support/citations.html">Attribution &amp; Citations</a></li>
					</ul>
				</section>

				<section class="footer-section ddc-mg-0">
					<h2 class='ddc-mgt-0'>Terms &amp; Privacy</h2>
					<ul class='ddc-list-unstyled ddc-mg-0'>
						<li><a href='/support/editorial_policy.html'>Editorial Policy</a></li>
						<li><a href='/support/privacy.html'>Privacy Policy</a>
						</li>
						<li><a href='/support/terms.html'>Terms of Use</a></li>
					</ul>
				</section>

				<div class="footer-section footer-social">
					<ul class="footer-social-list ddc-list-inline ddc-mgt-0 ddc-mgb-1">
						<li>
							<a href="https://www.facebook.com/Drugscom" target='_blank' rel='noopener' class="ddc-share-icon ddc-share-icon-facebook">
								<span class='ddc-share-icon-label'>Follow Drugs.com on Facebook</span> <svg class='ddc-icon ddc-icon-facebook' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M14 6.54c-2.06 0-3.4 1.25-3.4 3.52v2H8.3v2.61h2.3V21A9.04 9.04 0 013 12.05C3 7.05 7.03 3 12 3s9 4.05 9 9.05c0 4.53-3.3 8.27-7.6 8.95v-6.33h2.1l.4-2.62h-2.5v-1.7c0-.7.35-1.4 1.47-1.4h1.14V6.7s-1.03-.17-2.02-.17z' /></svg>							</a>
						</li>
						<li>
							<a href="https://twitter.com/drugscom" target='_blank' rel='noopener' class="ddc-share-icon ddc-share-icon-twitter">
								<span class='ddc-share-icon-label'>Follow Drugs.com on Twitter</span> <svg class='ddc-icon ddc-icon-twitter' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M8.66 19.63a10.44 10.44 0 0010.5-10.5v-.5A7.7 7.7 0 0021 6.74c-.67.3-1.39.5-2.12.58a3.73 3.73 0 001.64-2.04c-.72.43-1.52.74-2.34.9a3.7 3.7 0 00-6.3 3.36 10.46 10.46 0 01-7.61-3.85 3.69 3.69 0 001.14 4.9 3.66 3.66 0 01-1.63-.45v.04a3.7 3.7 0 002.9 3.64 3.7 3.7 0 01-1.63.06 3.69 3.69 0 003.42 2.53 7.4 7.4 0 01-4.6 1.64 8 8 0 01-.87-.07 10.45 10.45 0 005.66 1.63' /></svg>							</a>
						</li>
						<li>
							<a href="https://www.pinterest.com/drugscom/" target='_blank' rel='noopener' class="ddc-share-icon ddc-share-icon-pinterest">
								<span class='ddc-share-icon-label'>Follow Drugs.com on Pinterest</span> <svg class='ddc-icon ddc-icon-pinterest' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M11.97 3a9 9 0 00-3.29 17.36 8.48 8.48 0 010-2.57l1.06-4.5c-.16-.41-.25-.85-.24-1.29 0-1.25.73-2.19 1.63-2.19a1.14 1.14 0 011.14 1.29c0 .77-.49 1.93-.75 3a1.28 1.28 0 001.35 1.62c1.6 0 2.83-1.69 2.83-4.12a3.55 3.55 0 00-3.77-3.66 3.92 3.92 0 00-4.08 3.9c0 .74.22 1.46.65 2.06.06.07.09.16.06.25l-.25 1.03c-.02.12-.13.2-.3.12-1.13-.53-1.83-2.17-1.83-3.5 0-2.83 2.07-5.44 5.96-5.44 3.13 0 5.57 2.23 5.57 5.2 0 3.1-1.93 5.6-4.69 5.6-.82.02-1.6-.36-2.07-1.03l-.56 2.14a9.98 9.98 0 01-1.12 2.36c.87.25 1.79.38 2.7.37A9.02 9.02 0 0021 12c0-4.97-4.04-9-9.03-9' /></svg>							</a>
						</li>
						<li>
							<a href="https://www.youtube.com/user/drugscom" target='_blank' rel='noopener' class="ddc-share-icon ddc-share-icon-youtube">
								<span class='ddc-share-icon-label'>Follow Drugs.com on YouTube</span> <svg class='ddc-icon ddc-icon-youtube' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M12.25 5c.57 0 2.05.01 3.58.07l.5.01c1.45.06 2.85.16 3.48.32.86.22 1.54.86 1.77 1.68.38 1.33.42 3.96.42 4.5v.18c0 .53-.04 3.16-.42 4.5-.23.81-.9 1.46-1.77 1.68-1.33.34-6.12.39-7.46.4h-.71c-1.33-.01-6.12-.06-7.45-.4a2.45 2.45 0 01-1.77-1.69A22.62 22.62 0 012 11.76v-.19c0-.53.04-3.16.42-4.49.23-.82.9-1.46 1.77-1.68.63-.16 2.03-.26 3.47-.32l.51-.01C9.7 5 11.18 5 11.75 5zm-2.3 3.85v5.63l5.23-2.81-5.23-2.82z' /></svg>							</a>
						</li>
						<li>
							<a href="/newsletters/" title='Drugs.com RSS Feeds' class="ddc-share-icon">
								<span class='ddc-share-icon-label'>Subscribe to our Newsletters</span> <svg class='ddc-icon ddc-icon-email' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M20 4.25c.92 0 1.67.7 1.74 1.6l.01.15v12c0 .92-.7 1.67-1.6 1.74l-.15.01H4c-.92 0-1.67-.7-1.74-1.6L2.25 18V6c0-.92.7-1.67 1.6-1.74L4 4.25h16zm-.17 1.77a.75.75 0 00-1.06-.1L12 11.52l-6.77-5.6-.1-.06a.75.75 0 00-.86 1.22l7.25 6 .1.07c.27.15.61.13.86-.07l7.25-6L19.8 7a.75.75 0 00.02-.98z' /></svg>							</a>
						</li>
					</ul>
					<p class='ddc-mgb-1'><a href="/newsletters/">Subscribe</a> to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates.</p>
				</div>
			</div>

		</div>

		<div class='footer-description'>
			<p><strong>Drugs.com</strong> provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include IBM Watson Micromedex (updated 1 July 2021), Cerner Multum&trade; (updated 1 July 2021), ASHP (updated 30 June 2021) and others.</p>
		</div>

		<div class='footer-info ddc-clearfix'>

			<div class='footPrivacy'>
				<ul class="site-privacy ddc-list-unstyled ddc-mg-0">
					<li class="privacy-logo logo-truste ddc-clearfix">
						<a href='//privacy.truste.com/privacy-seal/validation?rid=d18cba4a-afc4-4863-af81-8262bb120271' target='_blank' rel='noopener'>
							<img data-lazy-load data-src='//privacy-policy.truste.com/privacy-seal/seal?rid=d18cba4a-afc4-4863-af81-8262bb120271' src='/img/pixel.gif' width='142' height='45' alt='TRUSTe'>
						</a>
					</li>
					<li class="privacy-logo logo-adchoices ddc-clearfix">
						<a href="/support/privacy/advertising.html">
							<img data-lazy-load data-src='/img/logo/vendor/adchoices-logomark.png' src='/img/pixel.gif' width='40' height='42' alt='AdChoices'>
							<span>
								<b>Ad Choices</b>
							</span>
						</a>
					</li>
					<li class="privacy-logo logo-honcode ddc-clearfix">
						<img data-lazy-load data-src='/img/logo/vendor/honcode-2020.png' src='/img/pixel.gif' width='43' height='60' alt='HonCode'>
						<span>We comply with the HONcode standard for trustworthy health information. <a class='ddc-text-nowrap' href='//www.hon.ch/HONcode/Conduct.html?HONConduct756274' target='_blank' rel='noopener nofollow'>Verify here</a></span>
					</li>
					<li class="site-info">
						<span>Copyright &copy; 2000-2021 Drugs.com. <span class='ddc-display-block'>All rights reserved.</span></span>
					</li>
				</ul>
			</div>
		</div>
	</div>
</footer>
<div class='ddc-social-share'></div>


<!-- Global JS var for configuration data/settings -->
<script>SITECONFIG = {"agent":{"isMobile":false},"user":{"userid":0,"modal":{"login":"/api/user/modal/login/"},"consent":{"skip":true,"api":{"url":"/api/user/"}}},"page":{"section":"pro","subsection":"","doc":"content","delayedCss":["/bundle/css/component/component.share.min.9d6804aa.css","/bundle/css/component/component.toast.min.c049fb21.css"],"delayedScripts":[],"image":{"lazyLoad":{"selector":"[data-lazy-load]","screens":1,"delay":2000}},"mailTo":{"delay":5000,"location":"/support/email-mailto.html"}},"form":{"recaptcha":{"sitekey":"6Ld-iSYTAAAAAOO0VTEwVl71HtvrFoSlPSibGr4g","callback":"DDC_RECAPTCHA_CALLBACK"}},"dwLog":{"a":1730,"b":16155,"c":"3,498,567,607","d":"119,121,149,326","e":"98,178","f":5271,"h":0,"i":"default","k":"3,498,567,607","l":"","m":"","n":"","o":"","p":0,"q":"drugs/pro"},"drugs":[{"ddc_id":1730,"brand_name_id":16155,"mtm_id":"d00555","generic_name":"norethindrone systemic","name":"Jencycla"}],"options":{"recordSelection":false,"classifyLists":{"wrapper":"#content","countHtmlItems":false,"numItems":{"short":10,"medium":25,"long":50},"charLimit":{"paragraph":30,"content":350}}},"subscribe":null,"dictionary":[],"share":{"sticky":{"target":".ddc-social-share"},"types":[{"title":"Facebook","label":"Share on Facebook","cssClass":"ddc-share-icon ddc-share-icon-facebook","labelClass":"ddc-share-icon-label","icon":"<svg class='ddc-icon ddc-icon-facebook' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M14 6.54c-2.06 0-3.4 1.25-3.4 3.52v2H8.3v2.61h2.3V21A9.04 9.04 0 013 12.05C3 7.05 7.03 3 12 3s9 4.05 9 9.05c0 4.53-3.3 8.27-7.6 8.95v-6.33h2.1l.4-2.62h-2.5v-1.7c0-.7.35-1.4 1.47-1.4h1.14V6.7s-1.03-.17-2.02-.17z' /></svg>","shareUrl":"https://www.facebook.com/sharer/sharer.php?u=SHAREURL","width":600,"height":500},{"title":"Twitter","label":"Share on Twitter","cssClass":"ddc-share-icon ddc-share-icon-twitter","labelClass":"ddc-share-icon-label","icon":"<svg class='ddc-icon ddc-icon-twitter' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M8.66 19.63a10.44 10.44 0 0010.5-10.5v-.5A7.7 7.7 0 0021 6.74c-.67.3-1.39.5-2.12.58a3.73 3.73 0 001.64-2.04c-.72.43-1.52.74-2.34.9a3.7 3.7 0 00-6.3 3.36 10.46 10.46 0 01-7.61-3.85 3.69 3.69 0 001.14 4.9 3.66 3.66 0 01-1.63-.45v.04a3.7 3.7 0 002.9 3.64 3.7 3.7 0 01-1.63.06 3.69 3.69 0 003.42 2.53 7.4 7.4 0 01-4.6 1.64 8 8 0 01-.87-.07 10.45 10.45 0 005.66 1.63' /></svg>","shareUrl":"https://twitter.com/intent/tweet?text=SHARETITLE&url=SHAREURL","width":600,"height":420},{"title":"Email","label":"Email to a friend","cssClass":"ddc-share-icon ddc-share-icon-email","labelClass":"ddc-share-icon-label","icon":"<svg class='ddc-icon ddc-icon-email' width='16' height='16' viewBox='0 0 24 24' aria-hidden='true' focusable='false' xmlns='http://www.w3.org/2000/svg'><path d='M20 4.25c.92 0 1.67.7 1.74 1.6l.01.15v12c0 .92-.7 1.67-1.6 1.74l-.15.01H4c-.92 0-1.67-.7-1.74-1.6L2.25 18V6c0-.92.7-1.67 1.6-1.74L4 4.25h16zm-.17 1.77a.75.75 0 00-1.06-.1L12 11.52l-6.77-5.6-.1-.06a.75.75 0 00-.86 1.22l7.25 6 .1.07c.27.15.61.13.86-.07l7.25-6L19.8 7a.75.75 0 00.02-.98z' /></svg>","mailUrl":"mailto:?body=https%3A%2F%2Fwww.drugs.com%2Fpro%2Fjencycla.html","width":600,"height":420}],"mednotes":{"apiUrl":"/mednotes/api/modal","saveButton":"data-modal-mednotes-save"}},"ads":{"section":"drugs/pro","ugc":false,"display":{"mobile":false,"logUrl":"/api/logger/ads/","units":[]},"injection":{"placeholder":[{"selector":"[data-ad-placeholder=TAP_NATIVE_AD]","ad":{"type":"TapNative","format":"fluid","buffer":0,"lazy":0.75},"buffer":{"before":800,"after":1000}}],"lazy":0.75,"maximum":{"ads":10,"tags":1000},"container":"#content","start":[".nav-tabs","h2","h1"],"stop":[".footer-feature","#sidebar"],"last":{"buffer":500},"insert":["section","h2","h3","h4","h5","p","ol","ul","table",".ddc-legend",".nav-tabs",".nav-tabs-group",".responsive-table-wrap"],"blacklist":["form","ol","ul","dl","table",".blackboxWarning",".column-split",".ddc-accordion",".ddc-box",".ddc-card",".ddc-card-group",".ddc-form-inline",".ddc-expand-read-more",".ddc-grid",".ddc-legend",".ddc-media",".ddc-navtree",".ddc-notification",".ddc-paging",".ddc-toc",".ddc-widget-calculator",".injection-ignore-inside",".nav-tabs",".nav-tabs-group",".paging-list-wrap",".responsive-table-wrap",".snippet",".ddc-official-answer"],"list":[{"type":"EHS","width":300,"height":250,"buffer":-1,"viewportPercent":75,"lazy":0.75,"data":{"size":"300x250","vpos":"b","hpos":"r","site":"ehs.pro.drugs.drugs","iprof":"md","ims1":"o24","drg":["norethindrone","Jencycla"],"drc":["contraceptives","progestins"],"dra":1}}]}},"nativeApp":{"version":0,"appSrc":"","memoryWarning":{"log":0,"ads":1}},"fixable":{"items":[{"targetSelector":".topbanner-wrap","delay":2500,"leaderboard":true},{"containerSelector":"#contentWrap","targetSelector":"#sideBoxStackedAd-1","delay":2500,"maximizeStickyHeight":true}]},"toc":[],"interaction":{"isDeferredSave":false,"url":"/interaction/list/","param":{"drugList":"drug_list","listId":"interaction_list_id"}},"identityLink":{"api":{"url":"/api/user/"},"cookie":{"link":"pbjs_identitylink","data":"pbjs_identitydata"}},"toast":{"show":{"wait":3000,"scroll":250},"url":"/orilissa.html","content":"<span>Learn about a treatment option for <span>Endometriosis</span></span>","classList":["ddc-toast-alert"],"cookie":{"name":"ts_slider","expires":30},"ga":{"category":"TreatmentSeeker","action":"Orilissa - Endometriosis","label":"FullBarBottom"},"gtm":{"data":{"event":"footer_toast","category":"Priority Drug Target","campaign":"Orilissa (BC)","content":"Learn about a treatment option for Endometriosis","drug_id":"3930-18899","drug_name":"Orilissa"}}},"moreResources":{"list-data-other-brands-professional":"<a href='/pro/norlyda.html'>Norlyda</a>, <a href='/pro/heather-tablets.html'>Heather</a>, <a href='/pro/deblitane.html'>Deblitane</a>, <a href='/pro/jolivette.html'>Jolivette</a>, <a href='/pro/nora-be.html'>Nora-Be</a>, <a href='/pro/incassia.html'>Incassia</a>, <a href='/pro/lyza-tablets.html'>Lyza</a>, <a href='/pro/sharobel.html'>Sharobel</a>, <a href='/pro/tulana.html'>Tulana</a>, <a href='/pro/lyleq.html'>Lyleq</a>, <a href='/pro/nor-qd.html'>Nor-QD</a>, <a href='/pro/norlyroc.html'>Norlyroc</a>"}};</script>

<script src='//www.google-analytics.com/analytics.js' defer></script>
<script>
(function(i,r){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();})(window,'ga');
ga('create', 'UA-78451-2', 'auto', {'siteSpeedSampleRate': 30, 'useAmpClientId': true});
ga('require', 'linkid', 'linkid.js');
ga('require', 'displayfeatures');
ga('set', 'anonymizeIp', true);
ga('set', {"dimension46":"no","dimension47":"no","dimension79":"Orilissa - Endometriosis","dimension82":"Yes","dimension1":"1730-16155","dimension26":";3;498;567;607;","dimension25":";4272;1825;1840;1670;","dimension11":"No","dimension43":"index\/follow","contentGroup1":"Drug","contentGroup2":"FDA Monographs","dimension24":"FDA Monographs","dimension16":"HCP","dimension17":"English","contentGroup3":"Very Long Page","dimension15":"No","dimension18":"Web","dimension59":"Yes"});
ga('send', 'pageview', {});
</script>
<script>
window.dataLayer = window.dataLayer || [];
window.dataLayer.push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
window.dataLayer.push({"event":"pageview","drug_name":"Jencycla","drug_id":"1730-16155","ddc_id":"1730","brand_name_id":"16155","condition_ids":";3;498;567;607;","zone_ids":";4272;1825;1840;1670;","user_signed_in":"No","user_ilink":"No","page_index_status":"index/follow","page_orphan":"No","page_traffic_op":"No","content_type":"Drug","content_section":"FDA Monographs","content_sub_section":"FDA Monographs","content_audience":"HCP","content_language":"English","content_size":"Very Long Page","content_ugc":"No","app_source":"Web","ads_pro":"Yes","ads_pdt_enabled":"Yes","ads_pdt_label":"Orilissa - Endometriosis"});

</script>
<script src='//www.googletagmanager.com/gtm.js?id=GTM-MZ4MM39' defer></script>

<script>
var AD_Z = 'drugs/pro';
var AD_T = "_('ugc','0')_('c1',['4272','1825','1840','1670'])_('d','1730')_('b','16155')_('c2',['3','498','567','607'])_('dc',['98','178'])_('mi','1')_('rx','1')_('c2o',['3','498','567','607'])";
var AD_PT = "_('ppro', ['md','o24'])";
</script>
<script src='/bundle/js/polyfill.min.b17ad879.js' defer></script>
<script src='/bundle/js/launch-base.min.100d9649.js' defer></script>
<script src='/bundle/js/module-subscribe.min.305e1074.js' defer></script>

<script>
var _comscore = _comscore || [];
_comscore.push({c1: '2', c2: '9355535'});
</script>
<script src='//sb.scorecardresearch.com/beacon.js' defer></script>
<noscript><img src='https://sb.scorecardresearch.com/p?c1=2&amp;c2=9355535&amp;cv=2.0&amp;cj=1' alt=''></noscript>
<div id='drugs-drugs-3' class='display-ad display-ad-inter'>
<script>
var ehs_ad_called = ++ehs_ad_called || 1;
</script>
</div>
<script src='//ads.ehealthcaresolutions.com/a/?adid=drugs-drugs-3&slotid=3&url=www.drugs.com%2Fpro%2Fjencycla.html&size=inter&vpos=t&hpos=r&site=ehs.pro.drugs.drugs&iprof=md&ims1=o24&drg=norethindrone&drg=Jencycla&drc=contraceptives&drc=progestins&dra=1' defer></script>
<script>
(function(){/*
 Copyright The Closure Library Authors.
 SPDX-License-Identifier: Apache-2.0
*/
'use strict';var g=function(a){var b=0;return function(){return b<a.length?{done:!1,value:a[b++]}:{done:!0}}},l=this||self,m=/^[\w+/_-]+[=]{0,2}$/,p=null,q=function(){},r=function(a){var b=typeof a;if("object"==b)if(a){if(a instanceof Array)return"array";if(a instanceof Object)return b;var c=Object.prototype.toString.call(a);if("[object Window]"==c)return"object";if("[object Array]"==c||"number"==typeof a.length&&"undefined"!=typeof a.splice&&"undefined"!=typeof a.propertyIsEnumerable&&!a.propertyIsEnumerable("splice"))return"array";
if("[object Function]"==c||"undefined"!=typeof a.call&&"undefined"!=typeof a.propertyIsEnumerable&&!a.propertyIsEnumerable("call"))return"function"}else return"null";else if("function"==b&&"undefined"==typeof a.call)return"object";return b},u=function(a,b){function c(){}c.prototype=b.prototype;a.prototype=new c;a.prototype.constructor=a};var v=function(a,b){Object.defineProperty(l,a,{configurable:!1,get:function(){return b},set:q})};var y=function(a,b){this.b=a===w&&b||"";this.a=x},x={},w={};var aa=function(a,b){a.src=b instanceof y&&b.constructor===y&&b.a===x?b.b:"type_error:TrustedResourceUrl";if(null===p)b:{b=l.document;if((b=b.querySelector&&b.querySelector("script[nonce]"))&&(b=b.nonce||b.getAttribute("nonce"))&&m.test(b)){p=b;break b}p=""}b=p;b&&a.setAttribute("nonce",b)};var z=function(){return Math.floor(2147483648*Math.random()).toString(36)+Math.abs(Math.floor(2147483648*Math.random())^+new Date).toString(36)};var A=function(a,b){b=String(b);"application/xhtml+xml"===a.contentType&&(b=b.toLowerCase());return a.createElement(b)},B=function(a){this.a=a||l.document||document};B.prototype.appendChild=function(a,b){a.appendChild(b)};var C=function(a,b,c,d,e,f){try{var k=a.a,h=A(a.a,"SCRIPT");h.async=!0;aa(h,b);k.head.appendChild(h);h.addEventListener("load",function(){e();d&&k.head.removeChild(h)});h.addEventListener("error",function(){0<c?C(a,b,c-1,d,e,f):(d&&k.head.removeChild(h),f())})}catch(n){f()}};var ba=l.atob("aHR0cHM6Ly93d3cuZ3N0YXRpYy5jb20vaW1hZ2VzL2ljb25zL21hdGVyaWFsL3N5c3RlbS8xeC93YXJuaW5nX2FtYmVyXzI0ZHAucG5n"),ca=l.atob("WW91IGFyZSBzZWVpbmcgdGhpcyBtZXNzYWdlIGJlY2F1c2UgYWQgb3Igc2NyaXB0IGJsb2NraW5nIHNvZnR3YXJlIGlzIGludGVyZmVyaW5nIHdpdGggdGhpcyBwYWdlLg=="),da=l.atob("RGlzYWJsZSBhbnkgYWQgb3Igc2NyaXB0IGJsb2NraW5nIHNvZnR3YXJlLCB0aGVuIHJlbG9hZCB0aGlzIHBhZ2Uu"),ea=function(a,b,c){this.b=a;this.f=new B(this.b);this.a=null;this.c=[];this.g=!1;this.i=b;this.h=c},F=function(a){if(a.b.body&&!a.g){var b=
function(){D(a);l.setTimeout(function(){return E(a,3)},50)};C(a.f,a.i,2,!0,function(){l[a.h]||b()},b);a.g=!0}},D=function(a){for(var b=G(1,5),c=0;c<b;c++){var d=H(a);a.b.body.appendChild(d);a.c.push(d)}b=H(a);b.style.bottom="0";b.style.left="0";b.style.position="fixed";b.style.width=G(100,110).toString()+"%";b.style.zIndex=G(2147483544,2147483644).toString();b.style["background-color"]=I(249,259,242,252,219,229);b.style["box-shadow"]="0 0 12px #888";b.style.color=I(0,10,0,10,0,10);b.style.display=
"flex";b.style["justify-content"]="center";b.style["font-family"]="Roboto, Arial";c=H(a);c.style.width=G(80,85).toString()+"%";c.style.maxWidth=G(750,775).toString()+"px";c.style.margin="24px";c.style.display="flex";c.style["align-items"]="flex-start";c.style["justify-content"]="center";d=A(a.f.a,"IMG");d.className=z();d.src=ba;d.style.height="24px";d.style.width="24px";d.style["padding-right"]="16px";var e=H(a),f=H(a);f.style["font-weight"]="bold";f.textContent=ca;var k=H(a);k.textContent=da;J(a,
e,f);J(a,e,k);J(a,c,d);J(a,c,e);J(a,b,c);a.a=b;a.b.body.appendChild(a.a);b=G(1,5);for(c=0;c<b;c++)d=H(a),a.b.body.appendChild(d),a.c.push(d)},J=function(a,b,c){for(var d=G(1,5),e=0;e<d;e++){var f=H(a);b.appendChild(f)}b.appendChild(c);c=G(1,5);for(d=0;d<c;d++)e=H(a),b.appendChild(e)},G=function(a,b){return Math.floor(a+Math.random()*(b-a))},I=function(a,b,c,d,e,f){return"rgb("+G(Math.max(a,0),Math.min(b,255)).toString()+","+G(Math.max(c,0),Math.min(d,255)).toString()+","+G(Math.max(e,0),Math.min(f,
255)).toString()+")"},H=function(a){a=A(a.f.a,"DIV");a.className=z();return a},E=function(a,b){0>=b||null!=a.a&&0!=a.a.offsetHeight&&0!=a.a.offsetWidth||(fa(a),D(a),l.setTimeout(function(){return E(a,b-1)},50))},fa=function(a){var b=a.c;var c="undefined"!=typeof Symbol&&Symbol.iterator&&b[Symbol.iterator];b=c?c.call(b):{next:g(b)};for(c=b.next();!c.done;c=b.next())(c=c.value)&&c.parentNode&&c.parentNode.removeChild(c);a.c=[];(b=a.a)&&b.parentNode&&b.parentNode.removeChild(b);a.a=null};var ia=function(a,b,c,d,e){var f=ha(c),k=function(n){n.appendChild(f);l.setTimeout(function(){f?(0!==f.offsetHeight&&0!==f.offsetWidth?b():a(),f.parentNode&&f.parentNode.removeChild(f)):a()},d)},h=function(n){document.body?k(document.body):0<n?l.setTimeout(function(){h(n-1)},e):b()};h(3)},ha=function(a){var b=document.createElement("div");b.className=a;b.style.width="1px";b.style.height="1px";b.style.position="absolute";b.style.left="-10000px";b.style.top="-10000px";b.style.zIndex="-10000";return b};var K={},L=null;var M=function(){},N="function"==typeof Uint8Array,O=function(a,b){a.b=null;b||(b=[]);a.j=void 0;a.f=-1;a.a=b;a:{if(b=a.a.length){--b;var c=a.a[b];if(!(null===c||"object"!=typeof c||Array.isArray(c)||N&&c instanceof Uint8Array)){a.g=b-a.f;a.c=c;break a}}a.g=Number.MAX_VALUE}a.i={}},P=[],Q=function(a,b){if(b<a.g){b+=a.f;var c=a.a[b];return c===P?a.a[b]=[]:c}if(a.c)return c=a.c[b],c===P?a.c[b]=[]:c},R=function(a,b,c){a.b||(a.b={});if(!a.b[c]){var d=Q(a,c);d&&(a.b[c]=new b(d))}return a.b[c]};
M.prototype.h=N?function(){var a=Uint8Array.prototype.toJSON;Uint8Array.prototype.toJSON=function(){var b;void 0===b&&(b=0);if(!L){L={};for(var c="ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789".split(""),d=["+/=","+/","-_=","-_.","-_"],e=0;5>e;e++){var f=c.concat(d[e].split(""));K[e]=f;for(var k=0;k<f.length;k++){var h=f[k];void 0===L[h]&&(L[h]=k)}}}b=K[b];c=[];for(d=0;d<this.length;d+=3){var n=this[d],t=(e=d+1<this.length)?this[d+1]:0;h=(f=d+2<this.length)?this[d+2]:0;k=n>>2;n=(n&
3)<<4|t>>4;t=(t&15)<<2|h>>6;h&=63;f||(h=64,e||(t=64));c.push(b[k],b[n],b[t]||"",b[h]||"")}return c.join("")};try{return JSON.stringify(this.a&&this.a,S)}finally{Uint8Array.prototype.toJSON=a}}:function(){return JSON.stringify(this.a&&this.a,S)};var S=function(a,b){return"number"!==typeof b||!isNaN(b)&&Infinity!==b&&-Infinity!==b?b:String(b)};M.prototype.toString=function(){return this.a.toString()};var T=function(a){O(this,a)};u(T,M);var U=function(a){O(this,a)};u(U,M);var ja=function(a,b){this.c=new B(a);var c=R(b,T,5);c=new y(w,Q(c,4)||"");this.b=new ea(a,c,Q(b,4));this.a=b},ka=function(a,b,c,d){b=new T(b?JSON.parse(b):null);b=new y(w,Q(b,4)||"");C(a.c,b,3,!1,c,function(){ia(function(){F(a.b);d(!1)},function(){d(!0)},Q(a.a,2),Q(a.a,3),Q(a.a,1))})};var la=function(a,b){V(a,"internal_api_load_with_sb",function(c,d,e){ka(b,c,d,e)});V(a,"internal_api_sb",function(){F(b.b)})},V=function(a,b,c){a=l.btoa(a+b);v(a,c)},W=function(a,b,c){for(var d=[],e=2;e<arguments.length;++e)d[e-2]=arguments[e];e=l.btoa(a+b);e=l[e];if("function"==r(e))e.apply(null,d);else throw Error("API not exported.");};var X=function(a){O(this,a)};u(X,M);var Y=function(a){this.h=window;this.a=a;this.b=Q(this.a,1);this.f=R(this.a,T,2);this.g=R(this.a,U,3);this.c=!1};Y.prototype.start=function(){ma();var a=new ja(this.h.document,this.g);la(this.b,a);na(this)};
var ma=function(){var a=function(){if(!l.frames.googlefcPresent)if(document.body){var b=document.createElement("iframe");b.style.display="none";b.style.width="0px";b.style.height="0px";b.style.border="none";b.style.zIndex="-1000";b.style.left="-1000px";b.style.top="-1000px";b.name="googlefcPresent";document.body.appendChild(b)}else l.setTimeout(a,5)};a()},na=function(a){var b=Date.now();W(a.b,"internal_api_load_with_sb",a.f.h(),function(){var c;var d=a.b,e=l[l.btoa(d+"loader_js")];if(e){e=l.atob(e);
e=parseInt(e,10);d=l.btoa(d+"loader_js").split(".");var f=l;d[0]in f||"undefined"==typeof f.execScript||f.execScript("var "+d[0]);for(;d.length&&(c=d.shift());)d.length?f[c]&&f[c]!==Object.prototype[c]?f=f[c]:f=f[c]={}:f[c]=null;c=Math.abs(b-e);c=1728E5>c?0:c}else c=-1;0!=c&&(W(a.b,"internal_api_sb"),Z(a,Q(a.a,6)))},function(c){Z(a,c?Q(a.a,4):Q(a.a,5))})},Z=function(a,b){a.c||(a.c=!0,a=new l.XMLHttpRequest,a.open("GET",b,!0),a.send())};(function(a,b){l[a]=function(c){for(var d=[],e=0;e<arguments.length;++e)d[e-0]=arguments[e];l[a]=q;b.apply(null,d)}})("__d3lUW8vwsKlB__",function(a){"function"==typeof window.atob&&(a=window.atob(a),a=new X(a?JSON.parse(a):null),(new Y(a)).start())});}).call(this);

window.__d3lUW8vwsKlB__("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");
</script>
</body>
</html>
